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Hypertension is a silent killer, and one-third of its sufferers are unaware of its presence. 
Earlier hypertension detection can control cardiovascular morbidity and mortality, and 
interventions associated with changes in daily lifestyle can cure this disease. The non-
invasive assessment of arterial stiffness has great significance for the monitoring of 
hypertension and related cardiovascular diseases (CVDs). However, the accuracy of 
current non-invasive assessments is usually poor due to the imprecise sensing of 
arterial waveforms. This study investigated non-invasive arterial stiffness assessment 
methods, using a piezoelectric sensor [ballistic pulse pressure (BPP)], compared with 
the use of the current state-of-the-art sensor, the photoplethysmogram (PPG) sensor, 
and further validated the BPP sensor against existing gold-standard devices and 
techniques. 
In this study, the viability of a low-cost alternative to tonometric devices was 
demonstrated, using a BPP sensor that was validated against the current gold-
standard tonometric device, with an r2 value of 0.86. The BPP sensor does not require 
an operator and is a wearable, low-cost sensor that can accurately assess arterial 
stiffness, and these advantages are discussed, in detail. Furthermore, this study 
demonstrated the trackability and responsiveness of BPP arterial waveforms 
compared with electrocardiogram (ECG) waveforms, using the heart rate variability 
(HRV) technique. The surrogacy of the BPP waveforms for ECG waveforms was also 
established when using the HRV technique, with an r2 value of 0.97. Another significant 
contribution of this study was the improvement of the pulse transit time (PTT) 
technique, which is conventionally used during cuffless blood pressure (BP) 
measurements. PTT measurements based on in-line BPP sensors were found to be 
more consistent for tracking fiducial parameters than current state-of-the-art in-line 
PPG sensors. 
Finally, the combination of both the BPP and PPG arterial waveforms resulted in the 
development of a novel, single-location estimation of arterial stiffness. The co-location 
of PPG and BPP sensors generated a pressure-volume loop, and the outcomes were 
reinforced by the phase-lag estimation between waveforms. This study was validated 
against the SphygmoCor carotid augmentation index, with an r2 value of 0.71, which 
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Introduction and Background to Arterial Waveform 
Analysis 
 
1.1 Motivation and Background 
Hypertension, which describes persistently elevated blood pressure (BP), is a curable, 
silent killer and has been reported to have a prevalence of 1.13 billion people, 
worldwide [1]. One-third of hypertension sufferers are unaware of their condition. Over 
the last two decades, arterial stiffness has emerged as an indicator of hypertension 
progression and cardiovascular disease (CVD) [2]. The European Society of 
Hypertension, in 2007, documented the importance of assessing arterial stiffness, 
which can be measured non-invasively [3]. The early detection of hypertension can 
control cardiovascular morbidity and mortality, and interventions, such as minor 
changes in daily lifestyle, can cure hypertension without requiring further medical 
interventions, like prescribed medications [4]. Arterial stiffness results in hypertension 
and CVD and can be measured non-invasively. The primary sources and associated 
signals used for the non-invasive assessment of arterial stiffness are as follows. 
• Arterial volumetric flow waveform 
• Arterial distension waveform  
• Arterial pressure waveform 
These signals can be clinically measured, using either invasive sensors or 
sophisticated non-invasive sensors, which are often limited by high costs and the lack 
of operational accuracy. These waveforms have been extensively researched for their 
use during the assessment of arterial stiffness [5][6]; however, currently, no clinically 
approved method is available. 
Arterial waveforms can be captured using various methodologies and the data 
corresponding to each method have different properties and provide different 
information, depending on the nature of the sensor assessment. The 
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photoplethysmogram (PPG) uses optical technology to obtain a volumetric blood flow 
waveform, based on light absorption by blood cells [7] and is commonly deployed in 
wearable technology for fitness tracking applications. Ultrasound devices can be used 
to measure the distension waveform, which describes arterial wall movement due to 
blood flow, particularly for larger arteries, such as the carotid and femoral arteries [8]. 
Tonometer devices, such as SphygmoCor and Compilor, can be used to measure 
pulse pressure, by partially occluding arterial blood flow [9].  
Although many studies have examined the non-invasive assessment of arterial 
stiffness during the last two decades, no method has been established that is cheap, 
user friendly, and can be used in wearable settings to provide data with clinical 
prognostic value. Although many previous studies have shown promising results for 
the non-invasive assessment of arterial stiffness, many methods lack performance 
accuracy. The current study describes a non-invasive and wearable solution for 
arterial stiffness measurements that can be used in clinical settings and home 
environments, with acceptable accuracies. 
 The research gaps are as follows: 
1. Heart rate variability (HRV) has not been tested and compared for distention 
waveforms and electrocardiogram (ECG) R-peaks. 
2. Arterial waveform analysis has not been compared, for arterial indexes, 
between distension waveforms and PPG-sensing technology. 
3. The pulse transit time (PTT) has not been compared across different sensing 
methodologies, such as arterial volumetric flow and arterial distension 
waveforms. 
4. The relationship between the arterial pressure waveform and the arterial 
volumetric flow waveform has not been evaluated in aspect waveforms data 
fusion. 
1.2 Aims and Objectives 
The primary aims of this study are to investigate non-invasive, arterial-stiffness-
assessment methods, by comparing the use of a piezoelectric sensor with the 
currently utilised state-of-the-art sensor, PPG, and to validate the piezoelectric sensor 
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against the tonometric gold standard, to evaluate the clinical feasibility of utilising this 
new sensor to monitor arterial stiffness. 
The main objectives of this work are listed below, based on the methodology used to 
compare the non-invasive sensor with the current state-of-the-art sensor and to 
validate the non-invasive sensor against the gold standards.  
• To test and validate the trackability of the arterial waveforms measured by the 
sensor, with respect to HRV of gold standard ECG sensor. 
• To test and validate the spatial and temporal haemodynamic indexes of arterial 
waveforms of gold standard tonometric sensor. 
• To compare the fiducial point of the arterial waveforms, for the analysis of PTT. 
Methodological comparisons and validations raise the question of whether information 
from various sensors can be combined (fused) to obtain additional information. 
Therefore, the last objective of the research was established:  
• To measure pulse wave velocity (PWV) and phase lag, from the fusion between 
arterial waveforms and their quantisation, against the SphygmoCor sensor. 
Background of Principles, Techniques, and Devices for Blood 
Pressure Measurement  
1.3 Hypertension  
Hypertension is a silent killer and represents the most significant challenge to public 
health, worldwide [1]. Hypertension morbidity increased dramatically, from 600 million 
to 1 billion patients, between 1980 and 2008; almost 40% of adults older than 25 years 
have been diagnosed with hypertension, worldwide, in 2008, according to the World 
Health Organization (WHO), 1 in 5 adults were hypertensive, and complications 
associated with hypertension cause 9.4 million deaths each year [1], which represents 
55.3% of all CVD deaths. A significant number of impediments identified in CVD are 
caused by hypertension. The most common complications include myocardial 
infarction, stroke, renal failure, and death, particularity if hypertension is not diagnosed 
and treated correctly [2]. The Joint National Committee (JNC), in its 8th edition, 
reported over 30% of hypertension-afflicted patients are unaware of their affliction and 
40% of hypertensive patients do not receive proper treatment for their conditions [3].  
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The force exerted by blood against the arterial walls during beat-to-beat blood flow is 
referred to as BP and is measured in units of millimetres of mercury (mmHg). The 
maximum pressure exerted during heart contraction referred to as systolic BP (SBP), 
whereas the minimum pressure exerted when the heart is at rest is referred to as 
diastolic BP (DBP). An example of a BP waveform is shown in Figure 1.1.  
 
Figure 1.1: Representative Blood Pressure Waveform [10] 
Hypertension, or high BP, is a stressed arterial condition, during which the blood flow 
waveform exerts persistently high pressure against the vessel walls. In healthy adults, 
the average SBP value is 120 mmHg and the average DBP value is 80 mmHg. The 
hypertensive condition increases health risks, especially for the heart and blood 
vessels in the kidney and brain.  
Current non-invasive BP measurement devices/systems are limited to systems that 
intermittently record snapshot BP measurements. Using these devices, 
measurements are not only burdensome but are also insufficient to evaluate dynamic 
parameters, which are vital for CVD treatment. The hypertension classifications are 
shown in Table 1.1. 
Table 1.1: Hypertension categories [11] 
Systolic (mmHg)  Diastolic (mmHg) Categories 
Below 120 And  Below 80 Normal Blood Pressure 
120–139 OR 80–89 Prehypertension 
140–159 OR 90–99 Stage 1 hypertension 
160 or more OR 100 or more Stage 2 hypertension 
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1.4 AAMI, BHS, and IEEE BP Device Standards 
The American Association for the Advancement of Medical Instrumentation (AAMI) 
standard states that a BP monitoring device under test (DUT) must not differ from the 
mercury standard by a mean difference > 5 mmHg or a standard deviation > 8 mmHg 
relative to a calibration device. The British Hypertension Society (BHS) standards for 
BP monitoring DUTs are given in Table 1.2. 
The Institute of Electrical and Electronics Engineers (IEEE) Std 1708-2014 is an IEEE 
Standard (under development) for wearable, cuff-less BP measuring devices, in 
compliance with the AAMI [12], BHS, and European Society for Hypertension (ESH) 
standards for DUT, as shown in Figure 1.2.  
Table 1.2: BHS classification level for BP Monitors [13] 
 The absolute difference between DUT and Standard Device 
(%) 
Grade  5  10  15 
A 60 85 95 
B 50 75 90 
C 40 65 80 
D                                  Worse than C 
 
 
Figure 1.2: IEEE Std 1708-2014 [14] 
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1.5 Arterial Stiffness 
Arterial stiffness is a predominant factor in CVD and PWV analysis can provide great 
insight into CVD-related conditions [15]. Arterial stiffness in hypertensive patients [16], 
[17] results in higher SBP and lower DBP, which can eventually cause an increase in 
the left ventricle (LV) afterload and alter coronary perfusion [18]. Radial SBP and pulse 
pressure becomes higher than the pressure in the ascending aorta due to pulse wave 
reflection [19], and central pressure is strongly related to vascular diseases [20]. 
Circadian rhythms and the BP cycle in response to sleep show BP variability of BP 
during the 24-h BP profile in daily life. BP tends to increase during the day, compared 
with that at night [21]. PWV is the gold-standard measurement for arterial stiffness, 
and a typical PWV value among healthy individuals is 7.6 m/s [22]. A PWV value of 12 
m/s is a fixed threshold for hypertension diagnosis, as stated in the 2007 
ESH/European Society for Cardiology (ESC) hypertension guidelines [23][24]. 
1.6 Invasive Systems 
1.6.1 Gold Standard: Invasive BP Measurements - Arterial Line 
The arterial line is the most accurate and continuous BP measurement method [17]. 
This technique has been practised since the early 19th century and continues to be 
considered the gold standard for BP measurements. A thin catheter is inserted into an 
artery, which can be the radial, carotid, femoral, dorsal pedal, or brachial artery, 
attached to a cannula needle, with an electronic pressure transducer that is connected 
to a fluid fill system that interfaces with a computer to calculate the BP waveform [25]. 
An arterial line can measure BP continuously, but its use is limited to the intensive 
care unit because of the delicate nature of its operation. A representative system is 
shown in Figure 1.3.  
 
Figure 1.3: Arterial Line [26] 
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1.7 Non-invasive System  
1.7.1 Snapshot Non-invasive Measurements 
Various methods can be used to measure BP from the brachial artery, by observing 
sounds during the forced closure of the artery, mediated by a cuff, followed by the 
controlled release of blood flow to normal conditions.  
1.7.1.1 Sphygmomanometer  
The sphygmomanometer method is an ancient method that was introduced during the 
last quarter of the 17th century. Since then, it has evolved to take different forms and 
shapes and relies on counterpressure measurements. At the time of its invention, a 
fluid-filled chamber was sealed around the wrist and submerged into a container. BP 
produced pressure changes in the chamber, which could be measured. Later, a 
waterfilled bag was attached to a mercury manometer and pressed against the wrist, 
to observe the arterial pulsation. SBP could be determined when sufficient pressure 
was exerted on the bag to halt the arterial pulsation in the hand. The hydraulic system, 
such as the Gibson apparatus shown in Figure 1.4, was subsequently replaced with a 
pneumatic pressure system, which was the predecessor of the cuff-based system that 
is currently used in clinical practice.  
 
Figure 1.4: Gibson BP measurement apparatus [27] 
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1.7.1.2 Auscultatory Method 
An auscultatory method is the most widely used method for measuring BP in the 
current clinical environment. At the start of the 19th century, Nikolai Korotkoff 
presented the measurement of BP in animals, using the Riva-Rocci sleeve, a 
manometer, and a stethoscope. This technique utilised an inflatable rubber cuff, which 
was strapped to the left arm, on the upper side. The device worked on collapse and 
controlled the release of blood flow in the brachial artery under the control of a 
pressurised hand pump cuff, as shown in Figure 1.5. The pump is connected to a 
mercury-filled scaled column or mechanical manometer, to measure the 
corresponding pressure. The cuff pressure is raised to stop the blood flow and then is 
gradually deflated, in a controlled manner, so that accompanying sounds of "beating" 
can be heard through a stethoscope placed onto the brachial artery by an observer, 
as shown in Figure 1.6. The first "beating" sound corresponds to SBP, and the 
pressure at which the "beating" stops indicates the DBP [28]. It is the easiest and the 
most efficient method to measure BP in clinics and the home environment. 
 
Figure 1.5: Sphygmomanometer [29] 
 





An oscillometric BP monitoring device uses an electronic pressure transducer, an 
automatic/semi-automatic cuff inflation and deflation system, and a controlled valve 
connected to an LCD screen to display the measured values. These devices remove 
the necessity of an observer during measurements. The cuff is strapped onto the left 
arm at the brachial artery, with the subject in the seated or supine position. 
Oscillometric BP monitors use the same principals as the auscultatory 
sphygmomanometer, but the cuff inflates using an electronic pump, to a pressure 
above SBP, and then deflates below DBP, through controlled release. The pneumatic 
values measure the mean arterial pressure (MAP), with the aid of an electronic 
transducer. A representative device is shown in Figure 1.7. An algorithm is used to 
make indirect measurements of SBP and DBP, as shown in Figure 1.8. Oscillometric 
devices that can be worn on the wrist are placed at the radial artery, which must be 
elevated to the heart level, although measurements taken at the upper arm tend to 
have higher accuracy. When oscillometric devices are compared against auscultatory 
devices using the AAMI standard a bias of 5 mmHg were found and oscillometric  are 
prone to error in subjects with arterial stiffness, atrial fibrillation, and pre-eclampsia 
[30]. 
  
Figure 1.7: Oscillometer device [31] 
 
Figure 1.8: BP measurement under the oscillometric principle [32] 
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1.8 Supervised, Cuffless Non-invasive Continuous BP Measurement 
1.8.1 Arterial Tonometry 
In 1862, Von Graefe developed the indentation tonometer, to measure the pressure 
of the eyeball, and, in 1867, his pupil, Weber, developed the applanation tonometer 
[10]. The principle of the Goldmann applanation tonometry states that when an artery 
is flattened against the bone through force, the internal pressure becomes equal to the 
externally applied pressure [11]. 
Tonometric devices use a manometer-tipped probe (pressure sensor) to measure the 
BP flow waveform, by flattening the artery against the bone. Tonometric devices follow 
the Laplace transformation principal, which states that when a circular tube, such as 
an artery, is flattened, so that radius increases to infinity, the internal pressure 
becomes the external pressure. The most suitable location for this measurement is 
the radial artery, which provides precise and reproducible waveform results. The radial 
artery applanation tonometry (AT) algorithm was established by the Food and Drug 
Administration of the USA [33].  
In the clinical environment, devices such as the sphygmomanometer and oscillometer 
utilise the peak and trough of the arterial waveform to assess CVD. To better assess 
the arterial waveform, an arterial tonometer can be used. When the carotid to radial 
transfer function is applied to the radial AT, the central BP can be determined. Central 
BP has been demonstrated to be a better predictor of CVD then to radial BP [34]. 
Representative, commercially available systems are shown in Figures 1.9 and 1.10. 
 




Figure 1.10: TL300 by Tensys medicals tonometer [36] 
1.8.2 Ambulatory Systems 
1.8.2.1 Volume Clamp Method 
Volume clamps use a pressurised optical cuff that wraps around the index finger. The 
pressure of the cuff varies, based on PPG waveforms, to maintain a constant optical 
sensor signal, which provides feedback for pressure uniformity. Because the blood 
volume and the light signal remain constant over time, the intra-arterial pressure is 
equal to the cuff pressure. VERIFI or PhysioCal algorithms are used to calculate BP. 
However, this non-invasive technology is sensitive to changes in vascular tone caused 
by the vasodilation and vasoconstriction of the smooth muscles of minor arteries, 
starting from arteria radialis moving to the periphery. In addition, the conventional cuff-
based oscillometric device continuously calibrates the device [37]. 
Penaz et. al. [38] developed a method for measuring the PPG waveform under a 
controlled cuff pressure, can remove motion-related artefacts. The pressure wave is 
frequently calibrated by cuff BP devices [39]. Two commercially popular devices are 
shown in Figures 1.11 and 1.12. 
 




Figure 1.12: Finapres Nova by Finapres [41] 
 
1.8.2.2 Ambulatory Arm Cuff-based BP Monitor 
In the clinical environment, especially in an intensive care unit, frequent BP 
measurements are necessary. Programmable devices are often used to measure the 
BP, based on the oscillometer principle. These devices can measure BP, with a 
minimum gap of 5 minutes, and generate a report for a 24-36-hour period. These 
machines can be accompanied by other diagnostic devices, such as ECG monitors 
and oximeters, as shown in Figure 1.13. The form factors of these BP monitors depend 
on their intended use, and some are built into wearable devices designed to measure 
hypertension and observe circadian rhythm, such as the device is shown in Figure 
1.13.  
               




1.9 Cuffless Blood Pressure Systems 
Various systems have been developed to measure BP without the use of a cuff, and 
researchers have shown great interest in this area since 2000. These devices aim to 
measure arterial stiffness, which can be used to estimate BP. Enormous research 
efforts and device development have occurred, with a few examples provided in 
Figures 1.14 to 1.18. The measurement principles for these devices are discussed in 
later sections. The use of these devices is limited because they lack the necessary 
precision and accuracy to meet the standards for BP measurements. 
 
  
Figure 1.14: Scanadu Scout [44] 
  
Figure 1.16: Visi Mobile [45] 
  
Figure 1.15: SOMNOtouch [46] 
  
Figure 1.17: BPro [47] 
 
 
Figure 1.18: PWV device Intelesens [48] 
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1.10 Review of Cuffless BP Techniques 
1.10.1 Pulse Arrival Time 
During the pulse arrival time (PAT) technique, the proximal signal is captured using an 
ECG sensor, and the distal signal is captured using a PPG sensor, which can be 
placed on the index finger, forehead, ear, or carotid artery. PAT refers to the time 
difference between the ECG R-Peak and the PPG foot, or systolic peak, or peak of 
first derivative or second derivative, as shown in Figure 1.19. PAT is a combination of 
the PTT and the pre-ejection period (PEP) [49]. The PEP is determined based on the 
electromechanical heart delay and isovolumic contraction period [50], where the PEP 
represents 10%-35% of the PTT [50]. BP estimations based on PAT are not precise 
because of the additional PEP delay, as demonstrated in clinical trials [51] - [74]. PAT 
is the most desirable parameter because it is an easy to obtain and robust 
measurement. PAT correlates more closely with SBP then with DBP [75]. SBP has 
been demonstrated to have a higher range than DBP during exertion-type 
interventions. In an invasive study, PAT was less correlated with SBP then DBP 
[49][76]. 
 
Figure 1.19: PAT measurement, based on ECG and PPG [77] 
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1.10.2 PPG Sensor with an Accelerometer[78]  
Researchers have combined a PPG sensor with an accelerometer, approximating BP 
using a non-invasive, wearable, PPG sensor ring, worn on the finger. The 
accelerometer measures hydrostatic pressure variations when strapped to the upper 
arm, on the left side. The Wiener model-based relationship between transmural 
pressure and the PPG waveform was able to extract arterial pressure from optical 
estimated waveforms [79]. 
1.10.3 Pulse Transit Time (PTT) 
PTT refers to the time difference between the proximal and distal waveforms. For this 
technique, two inline PPG sensors are placed on an artery to capture the proximal and 
distal waveforms, as shown in Figure 1.20. The fiducial points (the foot, systolic peak, 
the peaks of the first and second derivative, and intersecting tangents) are measured 
for each pulse waveform, and their time differences provide the PTT. Averaging PTT 
values over multiple cardiac cycles can reduce physiological artefacts [80][81]. Other 
important locations for measuring volumetric blood pulses include the radial artery, at 
the wrist and on the little finger (which target the ulnar and digital arteries, 
respectively), and height sensors are used to counteract hydrostatic pressure effects, 
shown in Figure 1.21. PTT is a ubiquitous technique with the potential to estimate BP 
[54], [59], [62]-[72], [82]–[92],  . PTT can be used to produce dynamic BP waveforms 
[93][94]. 
 




Figure 1.21: Inline PPG sensor, measuring PTT [28] 
1.10.4 Pulse Wave Velocity (PWV) 
The PWV measures the elasticity (or stiffness) of an artery, based on pressure 
waveforms. PWV-based arterial stiffness assessments can provide valuable 
information regarding CVD diseases [96]. PWV is measured as the ratio between 
distance of measurement location on an artery and PTT, which is mathematically 




)      (1.1) 
The PWV can be regional and local, depending on the measurement method. The 
regional method combines two similar sensors that can be located either inline or on 
two different branches of an arterial tree. Local PWV is measured by sensing pressure 
and flow arterial waveforms at the same location and is conventionally used by 
invasive sensors [97]. PWV can also be measured non-invasively, using an ultrasound 
sensor [8].  
1.11 Evolution of Pulse Wave Velocity for BP Measurements and 
Limitations 
The relationship between PWV and BP has been investigated by researchers over the 
last two decades, and promising evidence has indicated the existence of a direct 
relationship between these variables. However, two major problems have been 
identified with the use of PWV to estimate BP. First, PWV estimates can be inaccurate 
when using non-invasive sensors because of differences in the waveform origins, 
which can differ between the two measurement sites. Empirical calibrations and 
generalised transfer functions are often used to translate PWV measurements into BP 
estimates. Second, PWV varies with age, height, and ethnicity in normotensive 
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patients. Various techniques have been used to measure arterial stiffness, and their 
relationships with BP are described below. 
1.11.1  Inline Sensors 
For wearable applications, two surface-contact, polyvinylidene difluoride (PVDF) 
piezoelectric sensors are placed on the forearm, to measure arterial PTT from the 
brachial to the radial arteries, based on the pressure waveform, as shown in Figure 
1.22.  
 
Figure 1.22: PVDF sensor for PTT measurements [48] 
1.11.2  Carotid to Femoral PWV 
The conventional measurement technique uses a tonometric device, combined with a 
cuff. The cuff is strapped to the thigh on the subject’s femoral artery, and the 
tonometric sensor is placed on the carotid artery, as shown in Figure 1.23. The 
simultaneous acquisition of arterial waveforms provides the PWV, and the carotid to 
femoral length is calculated. The same procedure can be used without the cuff, by 
gating two waveforms taken at two different intervals at the carotid and femoral 
arteries. Aortic proximal and distal waveforms are predictors of cardiovascular risks 
[98].   
 
 
Figure 1.23: The operation of the AtCor PWV measurement system [35] 
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1.12 PTT Measurements by Eliminating PEP from PAT 
A researcher developed a technique for obtaining PTT measurements by eliminating 
the PEP from the PAT, using an ear-anchored device to measure integrated 
physiological signals, including the ballistocardiogram (BCG), PPG, and ECG. The 
BCG was estimated by an accelerometer sensor in the ear. A single-lead ECG was 
recorded using one electrode on the back of the neck, with a reference electrode at 
the mastoid, on the back of the ear. Reflectance PPG was acquired on the back of the 
ear. The sensory device was wirelessly connected to a PC, where the MAP showed a 
linear relationship to ln(1/PTT) [99]. A similar system used a weight scale to measure 
BCG signals, which was used to remove the PEP from the PAT [100], and the obtained 
signals are shown in Figure 1.24. 
 
Figure 1.24: Using BCG and PPG to measure PTT [100] 
1.13 Pulse Wave Analysis 
The pulse wave analysis can provide valuable diagnostic information regarding artery 
stiffness, based on contour properties. The contour properties can be determined 
using the forward and reflected waves of a standing wave in the arterial tress, which 
varies significantly according to artery elasticity. The types of arterial indexes can be 
based on spatial and/or temporal fiducial locations on the pulse contour. These arterial 





Figure 1.25: Digital plethysmogram (blue) and accelerated plethysmogram (red) 
[101] 
The most significant arterial indexes include the stiffness index (SI), reflection index 
(RI), aging index (AI), augmentation index (AIx), elasticity index (EI), cardiac ejection 
elasticity index (EEI), and dicrotic reflection index (DRI) [101]. The functional 
parameters of these arterial provide information regarding arterial stiffness. The 
arterial waveform systolic amplitude is directly proportional to local vascular 
distensibility [102] and correlates with SBP estimates [103]. The pulse width provides 
a direct relationship to vascular resistance [104]. The ratio of the area under the curve 
at the dicrotic notch is an indicator of peripheral resistance [105].  
1.14 Pressure-volume Loops 
1.14.1  Invasive Measurement 
PWV measurements that use the transit time of two pressure waves measure the 
average velocity, rather than the local PWV, due to the different compositions of 
arterial sites. For example, the aortic PWV measurement technique is a weighted 
average of wave speeds, as  wave at the carotid artery spends less time in the vessel 
compared with the same wave in the femoral artery, which spends a longer time on 
the arterial tree. When measuring the local pulse wave, knowing the arterial 
physiological information is advantageous. A transducer is inserted into an artery to 
measure pressure and volume, simultaneously. The velocity is measured as the slope 
of a linear portion of the pressure-volume loop (PU loop), as shown in Figure 1.26. 




Figure 1.26: PU Loop, generated based on the pressure and velocity waveforms. 
The red dotted line shows the slope (PWV) [97] 
1.14.2 Ultrasound-based BP Measurement 
Non-invasive assessments of local BP/PWV have enormous diagnostic potential for 
the early detection of CVD and the necessity of arteriovenous shunts during surgical 
operations. Ultrasound systems are used in clinical practice to evaluate blood flow 
velocity, volumetric blood flow, and arterial wall movements; however, the 
simultaneous acquisition of waveforms has been challenging. The simultaneous 
acquisition of flow and distension waveforms has not been viable using conventional 
models, such as Doppler velocity measurements and M-mode wall tracking. Two 
sensors have been used to assess average of velocity and distension waveform to 
obtain smoother results can cause temporal misalignment, as reported by Williams et 
al. [8]. In recent years, local PWV and vascular impedance assessment mechanisms 
have been successfully developed [8]. Uniform insonation and echo-tracking can 
measure the PWV, using the flow-area (QA) method, and the BP waveform can be 
estimated from the PWV waveform if DBP is known, using a cuff-based monitor [8]. 
However, the continuous or long-term exposure to ultrasound may warm the muscle, 
which limits its use for ambulatory assessments.  
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1.15 Sensor Location Placement Map 
1.15.1  Chest and Finger 
In the literature, researchers have used the PPG of the index finger to measure arterial 
waveforms, which provides the most accurate signal for this measurement. ECG 
signal is typically acquired based on Einthoven’s equilateral triangle, and various 
electrode placements are practised, with chest placement representing one of the 
most suitable locations [52], [53],[54],[55]–[57]. Various methods have been reported, 
in which PAT has been calculated from ECG and finger PPG [58],[91], [106]–[110], 
radial artery PPG [106], using reflectance PPG at the brachial artery [91],[109] or using 
EBI electrodes [58]. 
1.15.2  Forehead 
The forehead is one of the most stable points for reflected PPG signal acquisition 
because it provides the excellent and stable reflectance of incident wavelength on the 
bone. Researchers, worldwide, have exploited this feature to obtain signals for PAT 
[111]. In addition, mastoid locations have been tested by researchers and various 
possibilities at forehead for such scenarios. The PAT technique uses ECG and PPG 
sensors at the forehead or lower body [92][108][112] [108], transmission-mode PPG 
sensors on the earlobe [92], or a reflectance-mode PPG sensor on the buttocks (via a 
toilet seat) [112].  
1.15.3  PTT and PWV from Fingers and Toes 
As described above, the finger is one of the most suitable locations for PPG 
measurements, and the toe can be used similarly to the index finger [113]. The toe 
provides a point at a different length from the finger, allowing PWV to be calculated, 
which is not possible on when using the index fingers of both hands or adjacent fingers, 
index finger to ear and toe [87]. 
1.15.4  Carotid to Femoral Arteries 
During standard clinical practice, PWV measurements are obtained using the carotid 
and femoral arteries, with the time and distance relationships for the pulse to reach 
each location providing the PWV. PWV provides a measurement for aortic stiffness, 
and the sensors used for measurement include ultrasound and pulse tonometer. 
SphygmoCor and Compilior Ltd have developed commercial devices. PTT can also 
be estimated through central arteries [86][87]. 
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1.16 Calibration Mechanism 
BP estimations using PTT techniques have been calibrated using intervention 
techniques, which lower and raise BP. Common methods for raising BP in subjects 
include high-intensity exertion, such as cycling, running, and the Valsalva manoeuvre, 
whereas BP can be lowered using Muller’s manoeuvre or cold pressor methods [5]. 
Mental arithmetic and inverted image tracing-type techniques have also been reported 
in the literature, as shown in Table 1.3. For invasive procedures, pharmacological 
techniques have been used to lower or raise the BP [51], [59], [71]–[74], [82], [84], 
[86]–[89], [62], [90]–[92], [114]. 
Table 1.3: Intervention methods and their effects on BP [5] 
Intervention ∆SP/DP [mmHg] 
Cold Pressor 
+16/+14 (normal) 
+43/+31 (high BP) 
Sustained Handgrip +45 to 50/+40 (normal) 
Nitro-glycerine 
–17/–2 (Cath patients) 
–15/NA (outpatients) 
Neck Chamber –15/–15 (normal) 
Mental Arithmetic +20/+11 (normal) 
Slow Breathing –8/–5 (normal) 
Valsalva Maneuverer –15/–15 (normal) 
Posture < |10|/+4 (normal) 




1.17 Estimation of BP from PTT 
One of the methods used to estimate BP from PTT is by solving for MAP in Moens-
Korteweg equation and Young’s Modulus equation, as described [59], [65], [74], [87], 










ln (PTT)      (1.2) 
where ρ represents blood viscous density, h represents artery wall thickness, r 
represents the artery inner radius, 𝐸𝑜 represents the artery Young’s modulus, and 𝛥𝑋 
represents the heart to finger distance value [117]. 
Equation 1.2 can be used to determine BP, as follows: 
𝐵𝑃 =  𝐾1 ln(𝑃𝑇𝑇) + 𝐾2     (1.3) 
Another equation shape and form, using a non-linear approach and a quadratic 
function, has been tested, as follows [52], [67] [57], [76]: 
𝐵𝑃 =  
𝐾1
𝑃𝑇𝑇
+ 𝐾2      (1.4) 
To predict the asymptotic behaviour model, the following equation is used [118]. 
𝐵𝑃 =  
𝐾2
(𝑃𝑇𝑇−𝐾1)2
+ 𝐾3      (1.5) 
To estimate BP from PWV the following equation can be used: 
PWV (cm/ms) =  
BDC ×Height (cm)
PTT (ms)
       (1.6) 
BDC represents the body correlation factor and use as “0.5” as constant. 
BPPTT = P1 × PWV ×  e
P3×PWV + P2 × PWVP4 − (BPPTT,cal − BPcal)    (1.7) 
Where, P1 = 700, P2 = 766,000, P3 = –1, and P4 = 9, 𝐵𝑃𝑃𝑇𝑇,𝑐𝑎𝑙 represents the BP 
calculated from PTT at a calibrated BP, 𝐵𝑃𝑐𝑎𝑙 represents the cuff-based BP used for 
calibration, and 𝐵𝑃𝑃𝑇𝑇 represents the BP estimated from PTT [119].  
Another method that can be used to estimated BP from PTT [120] is shown below: 
SBP = 526.465 − 1.3813 PAT − 0.0012 HR − 0.0158 TDB − 0.0241 FET   (1.8) 
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DBP = 265.741 − 0.5681 PAT − 0.0299 HR − 0.0358 TDB − 0.00267 FET    (1.9) 
Where PAT is the pulse arrival time, HR is the heart rate, TDB is the arterial stiffness 
index, and FET is the femoral artery elastic wave. 
BP can also be estimated using the following method [121]: 
BPsys = 215 + 0.2886 PTTPPG − 0.8002PTTPressure     (1.10) 
BPdia = 123 + 0.4493 PTTPPG − 0.7239PTTPressure    (1.11) 
Where, 𝐵𝑃𝑠𝑦𝑠 is SBP, 𝑃𝑇𝑇𝑃𝑃𝐺 is the PPT from the PPG signal, 𝑃𝑇𝑇𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 is the PTT 
calculated from the pressure cuff, and 𝐵𝑃𝑑𝑖𝑎 is DBP. 
Regression analyses have been utilised to predict BP in the literature [62], [64], [85], 
[86], [89], [118], [66]–[73]. Least square regression has also been used for BP 
estimation [62], [67], [68], [72], [85], [86], [88], [90], [92]. Calibration intervals have 
been periodic for all methods. 
1.18 Summary 
Hypertension is among the largest challenges for healthcare systems, worldwide, and 
this chapter summarised the evolution of BP measurement methods, their importance, 
and currently accepted standards. Since ancient times, cuff-based devices have been 
key tools for measuring BP; however, no clinical-grade devices have been developed 
for the non-invasive, continuous, cuffless BP measurement. During the last two 
decades, PWV, PAT, PTT, PU-loops, and pulse wave morphology analysis techniques 
have been developed, producing clinically significant results. All of the cuffless BP 
estimation devices and their underlying techniques, which range from tonometric to 
wearable devices, require frequent calibration mechanisms that rely on conventional 
cuff-based BP measurements. The accuracies of these techniques do not currently 
meet the required AAMI/BHS standards. The tonometric and volume clamp methods 
produce clinical-grade information but lack accuracy due to the operational index and 
the complex control mechanism, respectively. In contrast, wearable techniques 
primarily rely on optical technologies, and the implied information is not as significant 
as information provided by other devices. This study has attempted to combine the 
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accuracy of a tonometric device into a wearable device, resulting in the development 
of a novel and accurate device for cuffless BP measurements.  
1.19 Overview of the Thesis 
This thesis consists of six chapters, including this introductory and background chapter 
reviewing arterial waveforms (Chapter 1). This chapter describes currently available 
measurement techniques and the ongoing, state-of-the-art research examining 
methods for the assessment of hypertension and its related parameters. This chapter 
also introduces the regulated standards available for the assessment of PB and their 
acceptable accuracy ranges. This chapter reviewed the historical development of BP 
sensors and the methods and waveforms used to measure BP and hypertension. Non-
invasive assessment methods, based on PPG, tonometric waveforms, and distension 
waveforms, were also reviewed. The precisions and accuracies of non-invasive 
sensors and methods were presented to highlight their shortcomings.  
Chapter 2 describes the cardiovascular mechanics underlying arterial waveforms, to 
provide background for the governing principles associated with BP measurements. 
The parameters necessary to quantify sensor waveforms are presented, to address 
the key objectives of this thesis. By the end of Chapter 3, current state-of-the-art 
sensing methodologies and their working principles will be explained. Chapter 3 
describes the mathematical derivation of blood flow and pressure waveforms and the 
relationships between these variables. The mathematical relationships among wave 
propagations are also derived in Chapter 3. Finally, the mathematical relationships 
between haemodynamic parameters and the arterial waveform are derived, to validate 
the theoretical information presented in previous chapters.  
Chapter 4 explains the experimental setup that was used to collect the novel dataset 
and describes the data acquisition platform, protocol, and sensors used for waveform 
acquisition. Furthermore, Chapter 4 demonstrates the methodology used to compare 
the waveforms obtained throughout the experimental study with their gold standards. 
Chapter 5 explains the results and findings from the experimental study described in 
Chapter 4 and discusses their relevance and limitations. Chapter 6 summarises the 
scientific findings and provides the main conclusions for this thesis. Chapter 6 also 




[1] World Health Organization, “A global brief on hypertension : silent killer, global 
public health crisis: World Health Day 2013,” 2013. 
[2] G. F. Mitchell, “Arterial stiffness and hypertension: chicken or egg?,” Hypertens. 
(Dallas, Tex.  1979), vol. 64, no. 2, pp. 210–4, Aug. 2014. 
[3] M. Ecobici and C. Stoicescu, “Arterial Stiffness and Hypertension - Which 
Comes First?,” Maedica (Buchar)., vol. 12, no. 3, pp. 184–190, Sep. 2017. 
[4] S. Elhani, T. J. Cleophas, and R. Atiqi, “Lifestyle interventions in the 
management of hypertension: a survey based on the opinion of 105 
practitioners.,” Neth. Heart J., vol. 17, no. 1, pp. 9–12, Jan. 2009. 
[5] R. Mukkamala, “Towards Ubiquitous Blood Pressure Monitoring via Pulse 
Transit Time: Theory and Practice,” IEEE Trans Biomed Eng., vol. 62, no. 8, pp. 
1879–1901, Aug. 2015. 
[6] W. W. Nichols, M. F. O’Rourke, C. Hartley, and D. A. McDonald, McDonald’s 
blood flow in arteries theoretic, experimental, and clinical principles. Arnold, 
1998. 
[7] A. B. Hertzman and C. R. Spealman, “Observations on the finger volume pulse 
recorded photoelectrically,” Am. J. Physiol., vol. 119, pp. 334–335, 1937. 
[8] B. W. A. M. M. Beulen, N. Bijnens, G. G. Koutsouridis, P. J. Brands, M. C. M. 
Rutten, and F. N. van de Vosse, “Toward Noninvasive Blood Pressure 
Assessment in Arteries by Using Ultrasound,” Ultrasound Med. Biol., vol. 37, no. 
5, pp. 788–797, May 2011. 
[9] M. Butlin and A. Qasem, “Large Artery Stiffness Assessment Using 
SphygmoCor Technology,” Pulse (Basel, Switzerland), vol. 4, no. 4, pp. 180–
192, Jan. 2017. 
[10] A. E. W. Johnson, “MIMIC-III, a freely accessible critical care database,” Sci. 
Data, vol. 3, p. 160035, May 2016. 
[11] A. V Chobanian, “The Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” 
27 
 
JAMA, vol. 289, no. 19, p. 2560, 2003. 
[12] S. Committee, I. Engineering, and B. Society, IEEE Standard for Wearable 
Cuffless Blood Pressure Measuring Devices. 2014. 
[13] P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, 
“Global burden of hypertension--analysis of worldwide data,” Lancet, vol. 365, 
pp. 217–223, 2005. 
[14] X. Zhou, W. Wu, and S. Bao, “[Mobile Health: IEEE Standard for Wearable 
Cuffless Blood Pressure Measuring Devices].,” Zhongguo Yi Liao Qi Xie Za Zhi, 
vol. 39, no. 4, pp. 285–7, Jul. 2015. 
[15] J. Allen, “Photoplethysmography and its application in clinical physiological 
measurement,” Physiol. Meas., vol. 28, no. 3, pp. R1–R39, Mar. 2007. 
[16] J. P. Lekakis, “Arterial stiffness assessed by pulse wave analysis in essential 
hypertension: Relation to 24-h blood pressure profile,” Int. J. Cardiol., vol. 102, 
no. 3, pp. 391–395, 2005. 
[17] J. P. Degaute, P. van de Borne, P. Linkowski, and E. Van Cauter, “Quantitative 
analysis of the 24-hour blood pressure and heart rate patterns in young men.,” 
Hypertension, 1991. 
[18] J. Blacher, A. P. Guerin, B. Pannier, S. J. Marchais, M. E. Safar, and G. M. 
London, “Impact of aortic stiffness on survival in end-stage renal disease.,” 
Circulation, vol. 99, no. 18, pp. 2434–9, 1999. 
[19] A. L. Pauca, M. F. O. Rourke, and N. D. Kon, “Prospective Evaluation of a 
Method for Estimating Ascending Aortic Pressure From the Radial Artery 
Pressure Waveform,” 2010. 
[20] M. J. Roman, “Central pressure more strongly relates to vascular disease and 
outcome than does brachial pressure: The strong heart study,” Hypertension, 
vol. 50, no. 1, pp. 197–203, 2007. 
[21] E. Koroboki, “Circadian Variation of Blood Pressure and Heart Rate in 
Normotensives, White-Coat, Masked, Treated and Untreated Hypertensives,” 
Hell. J. Cardiol., vol. 7, pp. 432–438, 2012. 
28 
 
[22] I. B. Wilkinson, J. R. Cockcroft, and D. J. Webb, “Pulse wave analysis and 
arterial stiffness.,” J. Cardiovasc. Pharmacol., vol. 32 Suppl 3, pp. S33-7, 1998. 
[23] P. Boutouyrie and S. J. Vermeersch, “Determinants of pulse wave velocity in 
healthy people and in the presence of cardiovascular risk factors: Establishing 
normal and reference values,” Eur. Heart J., vol. 31, no. 19, pp. 2338–2350, 
2010. 
[24] G. Mancia, “2013 ESH/ESC Guidelines for the management of arterial 
hypertension,” J. Hypertens., vol. 31, no. 7, pp. 1281–1357, Jul. 2013. 
[25] L. T. Hersh, B. Friedman, W. Luczyk, and J. Sesing, “Evaluation of filtering 
methods for acquiring radial intra-artery blood pressure waveforms,” J. Clin. 
Monit. Comput., vol. 29, no. 5, pp. 659–669, 2015. 
[26] K. Tegtmeyer, G. Brady, S. Lai, R. Hodo, and D. Braner, “Placement of an 
Arterial Line,” N. Engl. J. Med., vol. 354, no. 15, p. e13, Apr. 2006. 
[27] J. F. H.Dally, High Blood Pressure : Its Variations and Control. William 
Heinemann, 1934. 
[28] Atkins, O’Brien, Wesseling, and I. Guelen, “Increasing observer objectivity with 
audio-visual technology: the Sphygmocorder.,” Blood Press. Monit., vol. 2, no. 
5, pp. 269–272, Oct. 1997. 
[29] S. Blanchard, “ANATOMY AND PHYSIOLOGY,” in Introduction to Biomedical 
Engineering,  pp. 73–125, 2005. 
[30] M. Forouzanfar, S. Ahmad, I. Batkin, H. R. Dajani, V. Z. Groza, and M. Bolic, 
“Coefficient-Free Blood Pressure Estimation Based on Pulse Transit Time–Cuff 
Pressure Dependence,” IEEE Trans. Biomed. Eng., vol. 60, no. 7, pp. 1814–
1824, Jul. 2013. 
[31] G. Bilo, “Impact of cuff positioning on blood pressure measurement accuracy: 
may a specially designed cuff make a difference?,” Hypertens. Res., vol. 40, no. 
6, pp. 573–580, Jun. 2017. 
[32] C. F. Babbs, “Oscillometric measurement of systolic and diastolic blood 
pressures validated in a physiologic mathematical model.,” Biomed. Eng. 
29 
 
Online, vol. 11, p. 56, Aug. 2012. 
[33] E. D. M. Dias, “Carotid intima-media thickness is associated with cognitive 
deficiency in hypertensive patients with elevated central systolic blood 
pressure.,” Cardiovasc. Ultrasound, vol. 10, p. 41, 2012. 
[34] C. M. McEniery, J. R. Cockcroft, M. J. Roman, S. S. Franklin, and I. B. Wilkinson, 
“Central blood pressure: current evidence and clinical importance,” Eur. Heart 
J., vol. 35, no. 26, pp. 1719–25, Jul. 2014. 
[35] G. C. Cloud, C. rajkumar, J. Kooner, J. Cooke, and C. J. Bulpit, “Estimation of 
central aortic pressure by SphygmoCor® requires intra-arterial peripheral 
pressures,” Clin. Sci., vol. 105, no. 2, pp. 219–225, Aug. 2003. 
[36] A. S. Meidert, “Radial artery applanation tonometry for continuous non-invasive 
arterial pressure monitoring in intensive care unit patients: Comparison with 
invasively assessed radial arterial pressure,” Br. J. Anaesth., vol. 112, no. 3, pp. 
521–528, 2014. 
[37] J. Y. Wagner, “Continuous noninvasive arterial pressure measurement using the 
volume clamp method: an evaluation of the CNAP device in intensive care unit 
patients,” J. Clin. Monit. Comput., vol. 29, no. 6, pp. 807–813, 2015. 
[38] Penaz, “Photoelectric measurement of blood pressure, volume and flow in the 
finger,” Dig. 10th Int. Conf. Med. Biol. Eng., 1973. 
[39] B. P. Imholz, W. Wieling, G. A. van Montfrans, and K. H. Wesseling, “Fifteen 
years experience with finger arterial pressure monitoring: assessment of the 
technology.,” Cardiovasc. Res., vol. 38, no. 3, pp. 605–16, Jun. 1998. 
[40] J. Y. Wagner, J. Grond, J. Fortin, I. Negulescu, M. Schöfthaler, and B. Saugel, 
“Continuous noninvasive cardiac output determination using the CNAP system: 
evaluation of a cardiac output algorithm for the analysis of volume clamp 
method-derived pulse contour,” J. Clin. Monit. Comput., 2015. 
[41] Y. Van Der Does, “Non-invasive blood pressure and cardiac index 
measurements using the Finapres Portapres in an emergency department triage 
setting,” Am. J. Emerg. Med., vol. 31, no. 7, pp. 1012–1016, 2013. 
30 
 
[42] “Smartsigns Compact 300 Monitor | Obstetrics Patient Monitoring | Smartsigns 
| Monitors | Huntleigh Healthcare Limited | Huntleigh Diagnostic Products 
Division | Part of the Getinge Group.” [Online]. Available: http://www.huntleigh-
diagnostics.com/store/obstetric-monitoring/patient-monitoring/smartsigns-
compact-300. [Accessed: 20-May-2019]. 




[44] J. A. Walsh, E. J. Topol, and S. R. Steinhubl, “Novel Wireless Devices for 
Cardiac Monitoring,” Circulation, vol. 130, no. 7, pp. 573–581, Aug. 2014. 
[45] G. Guanqun Zhang, S. A. McCombie, R. Greenstein, and D. B. McCombie, 
“Assessing the challenges of a pulse wave velocity based blood pressure 
measurement in surgical patients,” in 2014 36th Annual International 
Conference of the IEEE Engineering in Medicine and Biology Society, 2014, vol.  
pp. 574–577, 2014. 
[46] L. S. Manning, T. G. Robinson, and R. B. Panerai, “The SOMNOtouch device 
as a novel method for measuring short-term blood pressure variability,” Blood 
Press. Monit., vol. 20, no. 6, pp. 361–368, Dec. 2015. 
[47] K.-G. Ng, “Progress on the development of the MediWatch ambulatory blood 
pressure monitor and related devices,” Blood Press. Monit., vol. 9, no. 3, pp. 
149–65, Jun. 2004. 
[48] J. McLaughlin, M. McNeill, B. Braun, and P. D. McCormack, “Piezoelectric 
sensor determination of arterial pulse wave velocity,” Physiol. Meas., vol. 24, no. 
3, pp. 693–702, Aug. 2003. 
[49] L. A. Geddes, M. H. Voelz, C. F. Babbs, J. D. Bourland, and W. A. Tacker, “Pulse 
transit time as an indicator of arterial blood pressure,” Psychophysiology, vol. 
18, no. 1, pp. 71–4, Jan. 1981. 
[50] W. S. Harris, C. D. Schoenfeld, and A. M. Weissler, “Effects of Adrenergic 
Receptor Activation and Blockade on the Systolic Preejection Period, Heart 
31 
 
Rate, and Arterial Pressure in Man,” J. Clin. Invest., vol. 46, no. 11, pp. 1704–
1714, Nov. 1967. 
[51] H. Gesche, D. Grosskurth, G. Küchler, and A. Patzak, “Continuous blood 
pressure measurement by using the pulse transit time: Comparison to a cuff-
based method,” Eur. J. Appl. Physiol., vol. 112, no. 1, pp. 309–315, Jan. 2012. 
[52] G. Jeong, K. Yu, and N. Kim, “Continuous Blood Pressure Monitoring using 
Pulse Wave Transit Time,” Measurement, pp. 2–5, 2005. 
[53] S. Ye, G. Kim, and D. Jung, “Estimation of systolic and diastolic pressure using 
the pulse transit time,” World Academy of Science, vol. 43, no. 7, pp. 726–731, 
2010. 
[54] R. Magjarevic, Measuring Blood Pressure Using a Photoplethysmography 
Approach, vol. 21,, Heidelberg: Springer Berlin Heidelberg, 2008. 
[55] C. Yu, “Optomechanical magnetometry with a macroscopic resonator,” IEEE 
Sens. J., vol. 14, no. 10, pp. 3490–3497, Oct. 2015. 
[56] S. Fuke, T. Suzuki, K. Nakayama, H. Tanaka, and S. Minami, “Blood pressure 
estimation from pulse wave velocity,” 35th Annu. Int. Conf. IEEE EMBS, pp. 
6107–6110, 2013. 
[57] S. Mazaheri, “A Comparative Review of Blood Pressure Measurement Methods 
Using Pulse Wave Velocity,” IEEE International Conference on Smart 
Instrumentation, Measurement and Applications (ICSIMA), pp 1-5, Kuala 
Lumpur, 2014. 
[58] C. Douniama, C. Sauter, and R. Couronné, “Blood pressure tracking capabilities 
of pulse transit times in different arterial segments: A clinical evaluation,” 36th 
Annu. Comput. Cardiol. Conf., pp. 201–204, 2009. 
[59] C. C. Y. Poon and Y. T. Zhang, “Cuff-less and Noninvasive Measurements of 
Arterial Blood Pressure by Pulse Transit Time,” in 2005 IEEE Engineering in 
Medicine and Biology 27th Annual Conference, 2005, vol. 6, pp. 5877–5880. 
[60] R. A. Payne, C. N. Symeonides, D. J. Webb, and S. R. J. Maxwell, “Pulse transit 
time measured from the ECG: an unreliable marker of beat-to-beat blood 
32 
 
pressure,” J. Appl. Physiol., vol. 100, no. 1, pp. 136–141, Jan. 2006. 
[61] C. Ahlstrom, A. Johansson, F. Uhlin, T. Länne, and P. Ask, “Noninvasive 
investigation of blood pressure changes using the pulse wave transit time: a 
novel approach in the monitoring of hemodialysis patients,” J. Artif. Organs, vol. 
8, no. 3, pp. 192–197, Oct. 2005. 
[62] Y. Choi, Q. Zhang, and S. Ko, “Noninvasive cuffless blood pressure estimation 
using pulse transit time and Hilbert–Huang transform,” Comput. Electr. Eng., vol. 
39, no. 1, pp. 103–111, Jan. 2013. 
[63] D. Spulak, R. Cmejla, and V. Fabian, “Parameters for mean blood pressure 
estimation based on electrocardiography and photoplethysmography,” in 2011 
International Conference on Applied Electronics,  no. 2, pp. 1–4, 2011. 
[64] I. cheol Jeong, J. Wood, and J. Finkelstein, “Using individualized pulse transit 
time calibration to monitor blood pressure during exercise,” Stud. Health 
Technol. Inform., vol. 190, pp. 39–41, 2013. 
[65] W. Chen, T. Kobayashi, S. Ichikawa, Y. Takeuchi, and T. Togawa, “Continuous 
estimation of systolic blood pressure using the pulse arrival time and intermittent 
calibration,” Med. Biol. Eng. Comput., vol. 38, no. 5, pp. 569–74, Sep. 2000. 
[66] Y. S. Yan and Y. T. Zhang, “A Novel Calibration Method for Noninvasive Blood 
Pressure Measurement Using Pulse Transit Time,” in 2007 4th IEEE/EMBS 
International Summer School and Symposium on Medical Devices and 
Biosensors, pp. 22–24, 2007. 
[67] F. S. Cattivelli and H. Garudadri, “Noninvasive Cuffless Estimation of Blood 
Pressure from Pulse Arrival Time and Heart Rate with Adaptive Calibration,” in 
2009 Sixth International Workshop on Wearable and Implantable Body Sensor 
Networks, pp. 114–119, 2009. 
[68] M. Masè, W. Mattei, R. Cucino, L. Faes, and G. Nollo, “Feasibility of cuff-free 
measurement of systolic and diastolic arterial blood pressure,” J. Electrocardiol., 
vol. 44, no. 2, pp. 201–207, Mar. 2011. 
[69] J. Muehlsteff, X. L. Aubert, and M. Schuett, “Cuffless Estimation of Systolic 
33 
 
Blood Pressure for Short Effort Bicycle Tests: The Prominent Role of the Pre-
Ejection Period,” in 2006 International Conference of the IEEE Engineering in 
Medicine and Biology Society, vol. 1, pp. 5088–5092, 2006. 
[70] Y. Yoon, J. H. Cho, and G. Yoon, “Non-constrained blood pressure monitoring 
using ECG and PPG for personal healthcare.,” J. Med. Syst., vol. 33, no. 4, pp. 
261–6, Aug. 2009. 
[71] A. Jadooei, O. Zaderykhin, and V. I. Shulgin, “Adaptive algorithm for continuous 
monitoring of blood pressure using a pulse transit time,” in 2013 IEEE XXXIII 
International Scientific Conference Electronics and Nanotechnology (ELNANO),  
pp. 297–301, 2013. 
[72] H. T. Ma, “A Blood Pressure Monitoring Method for Stroke Management,” 
Biomed Res. Int., vol. 2014, pp. 1–7, 2014. 
[73] S. S. Thomas, “BioWatch &amp;#x2014; A wrist watch based signal acquisition 
system for physiological signals including blood pressure,” in 2014 36th Annual 
International Conference of the IEEE Engineering in Medicine and Biology 
Society, 2014, vol., pp. 2286–2289, 2014. 
[74] B. M. McCarthy, B. O’Flynn, and A. Mathewson, “An Investigation of Pulse 
Transit Time as a Non-Invasive Blood Pressure Measurement Method,” J. Phys. 
Conf. Ser., vol. 307, no. 1, p. 012060, Aug. 2011. 
[75] A. M. Katz, “Physiology of the heart,” Clin. Cardiol., vol. 4, no. 4, pp. 196–196, 
Jul. 1981. 
[76] G. Zhang, M. Gao, D. Xu, N. B. Olivier, and R. Mukkamala, “Pulse arrival time 
is not an adequate surrogate for pulse transit time as a marker of blood 
pressure,” J. Appl. Physiol., vol. 111, no. 6, pp. 1681–1686, Dec. 2011. 
[77] Q. Zhang, “Cuff-less blood pressure measurement using pulse arrival time and 
a Kalman filter,” J. Micromechanics Microengineering, vol. 27, no. 2, p. 024002, 
Feb. 2017. 
[78] P. A. Shaltis, A. Reisner, and H. H. Asada, “Wearable, Cuff-less PPG-Based 
Blood Pressure Monitor with Novel Height Sensor,” in 2006 International 
34 
 
Conference of the IEEE Engineering in Medicine and Biology Society, vol. 1, pp. 
908–911, 2006. 
[79] A. Marinkovid, A. Marinkovid, H. H. Asada, T. Supervisor, and L. Anand, 
“Reconstructing the Blood Pressure Waveform using a Wearable,” 39th Annual 
International Conference of the IEEE Engineering in Medicine and Biology 
Society (EMBC), Seogwipo, pp. 821-824, 2007. 
[80] R. Asmar, “Assessment of arterial distensibility by automatic pulse wave velocity 
measurement. Validation and clinical application studies,” Hypertens. (Dallas, 
Tex.  1979), vol. 26, no. 3, pp. 485–90, Sep. 1995. 
[81] W. Lu, “Research on the main elements influencing blood pressure 
measurement by pulse wave velocity.,” Front. Med. Biol. Eng., vol. 4, no. 3, pp. 
189–99, 1992. 
[82] B. M. McCarthy, C. J. Vaughan, B. O’Flynn, A. Mathewson, and C. Ó Mathúna, 
“An examination of calibration intervals required for accurately tracking blood 
pressure using pulse transit time algorithms,” J. Hum. Hypertens., vol. 27, no. 
12, pp. 744–750, Dec. 2013. 
[83] J. E. Davies, “Use of simultaneous pressure and velocity measurements to 
estimate arterial wave speed at a single site in humans,” Am J Physiol Heart 
Circ Physiol. 290(2), pp 878-85,  2006. 
[84] B. Gribbin, A. Steptoe, and P. Sleight, “Pulse wave velocity as a measure of 
blood pressure change.,” Psychophysiology, vol. 13, no. 1, pp. 86–90, Jan. 
1976. 
[85] H. Gesche, D. Grosskurth, G. Küchler, and A. Patzak, “Continuous blood 
pressure measurement by using the pulse transit time: comparison to a cuff-
based method,” Eur. J. Appl. Physiol., vol. 112, no. 1, pp. 309–315, Jan. 2012. 
[86] J. Sola, “Noninvasive and Nonocclusive Blood Pressure Estimation Via a Chest 
Sensor,” IEEE Trans. Biomed. Eng., vol. 60, no. 12, pp. 3505–3513, Dec. 2013. 
[87] Y. Chen, C. Wen, G. Tao, M. Bi, and G. Li, “Continuous and Noninvasive Blood 
Pressure Measurement: A Novel Modeling Methodology of the Relationship 
35 
 
Between Blood Pressure and Pulse Wave Velocity,” Ann. Biomed. Eng., vol. 37, 
no. 11, pp. 2222–2233, Nov. 2009. 
[88] D. B. McCombie, A. T. Reisner, and H. H. Asada, “Motion based adaptive 
calibration of pulse transit time measurements to arterial blood pressure for an 
autonomous, wearable blood pressure monitor,” in 2008 30th Annual 
International Conference of the IEEE Engineering in Medicine and Biology 
Society, 2008, vol., pp. 989–992, 2008. 
[89] C. C. Young, J. B. Mark, W. White, A. DeBree, J. S. Vender, and A. Fleming, 
“Clinical evaluation of continuous noninvasive blood pressure monitoring: 
accuracy and tracking capabilities.,” J. Clin. Monit., vol. 11, no. 4, pp. 245–52, 
Jul. 1995. 
[90] M. Mingwu Gao and R. Mukkamala, “Perturbationless calibration of pulse transit 
time to blood pressure,” in 2012 Annual International Conference of the IEEE 
Engineering in Medicine and Biology Society,, pp. 232–235, 2012. 
[91] P. Rai et al., “Smart healthcare textile sensor system for unhindered-pervasive 
health monitoring,” SPIE Proceedings, vol. 8344, 2012. 
[92] G. Lopez, “Continuous Blood Pressure Monitoring in Daily Life,” J. Adv. Mech. 
Des. Syst. Manuf., vol. 4, no. 1, pp. 179–186, 2010. 
[93] D. B. McCombie, “Development of a wearable blood pressure monitor using 
adaptive calibration of peripheral pulse transit time measurements,” Thesis (Ph. 
D.) Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 
2008. 
[94] K. Li and S. Warren, “A Wireless Reflectance Pulse Oximeter With Digital 
Baseline Control for Unfiltered Photoplethysmograms,” IEEE Trans. Biomed. 
Circuits Syst., vol. 6, no. 3, pp. 269–278, Jun. 2012. 
[95] A.-G. Pielmus, “Novel computation of pulse transit time from multi-channel PPG 
signals by wavelet transform,” Curr. Dir. Biomed. Eng., vol. 2, no. 1, pp. 209–
213, Jan. 2016. 
[96] C. M. McClean, “The effect of acute aerobic exercise on pulse wave velocity and 
36 
 
oxidative stress following postprandial hypertriglyceridemia in healthy men,” 
Eur. J. Appl. Physiol., vol. 100, no. 2, pp. 225–234, 2007. 
[97] K. H. Parker, “An introduction to wave intensity analysis,” Med. Biol. Eng. 
Comput., vol. 47, no. 2, pp. 175–188, Feb. 2009. 
[98] S. Laurent, “Expert consensus document on arterial stiffness: methodological 
issues and clinical applications,” Eur. Heart J., vol. 27, no. 21, pp. 2588–2605, 
Sep. 2006. 
[99] E. S. Winokur, “Single-Site, Noninvasive, Blood Pressure Measurements at the 
Ear using Ballistocardiogram (BCG), and Photoplethysmogram (PPG), and a 
Low-Power, Reflectance-Mode PPG SoC,” 2013. 
[100] S. L.-O. Martin, “Weighing Scale-Based Pulse Transit Time is a Superior Marker 
of Blood Pressure than Conventional Pulse Arrival Time,” Sci. Rep., vol. 6, no. 
1, p. 39273, Dec. 2016. 
[101] E. von Wowern, G. Östling, P. M. Nilsson, and P. Olofsson, “Digital 
Photoplethysmography for Assessment of Arterial Stiffness: Repeatability and 
Comparison with Applanation Tonometry,” PLoS One, vol. 10, no. 8, p. 
e0135659, Aug. 2015. 
[102] J. C. Dorlas and J. A. Nijboer, “Photo-electric plethysmography as a monitoring 
device in anaesthesia. Application and interpretation.,” Br. J. Anaesth., vol. 57, 
no. 5, pp. 524–30, May 1985. 
[103] E. C.-P. Chua, S. J. Redmond, G. McDarby, and C. Heneghan, “Towards Using 
Photo-Plethysmogram Amplitude to Measure Blood Pressure During Sleep,” 
Ann. Biomed. Eng., vol. 38, no. 3, pp. 945–954, Mar. 2010. 
[104] A. A. Awad, “The relationship between the photoplethysmographic waveform 
and systemic vascular resistance,” J. Clin. Monit. Comput., vol. 21, no. 6, pp. 
365–372, Nov. 2007. 
[105] L. Wang, E. Pickwell-MacPherson, Y. P. Liang, and Y. T. Zhang, “Noninvasive 
cardiac output estimation using a novel photoplethysmogram index,” in 2009 
Annual International Conference of the IEEE Engineering in Medicine and 
37 
 
Biology Society, pp. 1746–1749, 2009. 
[106] J. D. Lane, L. Greenstadt, D. Shapiro, and E. Rubinstein, “Pulse transit time and 
blood pressure: an intensive analysis.,” Psychophysiology, vol. 20, no. 1, pp. 
45–9, Jan. 1983. 
[107] A. Steptoe, H. Smulyan, and B. Gribbin, “Pulse wave velocity and blood 
pressure change: calibration and applications.,” Psychophysiology, vol. 13, no. 
5, pp. 488–93, Sep. 1976. 
[108] P. A. Obrist, K. C. Light, J. A. McCubbin, J. S. Hutcheson, and J. L. Hoffer, 
“Pulse transit time: relationship to blood pressure and myocardial performance.,” 
Psychophysiology, vol. 16, no. 3, pp. 292–301, May 1979. 
[109] Y.-L. Ya-Li Zheng, B. P. Yan, Y.-T. Yuan-Ting Zhang, and C. C. Y. Poon, “An 
Armband Wearable Device for Overnight and Cuff-Less Blood Pressure 
Measurement,” IEEE Trans. Biomed. Eng., vol. 61, no. 7, pp. 2179–2186, Jul. 
2014. 
[110] G. V Marie, C. R. Lo, J. Van Jones, and D. W. Johnston, “The relationship 
between arterial blood pressure and pulse transit time during dynamic and static 
exercise.,” Psychophysiology, vol. 21, no. 5, pp. 521–7, Sep. 1984. 
[111] L. A. Geddes, M. Voelz, S. James, and D. Reiner, “Pulse arrival time as a 
method of obtaining systolic and diastolic blood pressure indirectly.,” Med. Biol. 
Eng. Comput., vol. 19, no. 5, pp. 671–2, Sep. 1981. 
[112] J. S. Kim, Y. J. Chee, J. W. Park, J. W. Choi, and K. S. Park, “A new approach 
for non-intrusive monitoring of blood pressure on a toilet seat,” Physiol. Meas., 
vol. 27, no. 2, pp. 203–211, Feb. 2006. 
[113] Snapshots of Hemodynamics, vol. 18. Boston: Kluwer Academic Publishers, 
2005. 
[114] D. J. Hughes, C. F. Babbs, L. A. Geddes, and J. D. Bourland, “Measurements 
of Young’s Modulus of Elasticity of the Canine Aorta with Ultrasound,” Ultrason. 
Imaging, vol. 1, no. 4, pp. 356–367, Oct. 1979. 
[115] T. Wibmer, “Blood pressure monitoring during exercise: Comparison of pulse 
38 
 
transit time and volume clamp methods.,” Blood Press., vol. 24, no. 6, pp. 353–
60, 2015. 
[116] C. C. Y. Poon, Y. Zhang, and Y. Liu, “Modeling of Pulse Transit Time under the 
Effects of Hydrostatic Pressure for Cuffless Blood Pressure Measurements,” in 
2006 3rd IEEE/EMBS International Summer School on Medical Devices and 
Biosensors, pp. 65–68, 2006. 
[117] E. Hermeling, “The change in arterial stiffness over the cardiac cycle rather than 
diastolic stiffness is independently associated with left ventricular mass index in 
healthy middle-aged individuals,” J. Hypertens., vol. 30, no. 2, pp. 396–402, Feb. 
2012. 
[118] T. Wibmer, “Pulse transit time and blood pressure during cardiopulmonary 
exercise tests.,” Physiol. Res., vol. 63, no. 3, pp. 287–96, 2014. 
[119] G. J. Langewouters, K. H. Wesseling, and W. J. Goedhard, “The static elastic 
properties of 45 human thoracic and 20 abdominal aortas in vitro and the 
parameters of a new model.,” J. Biomech., vol. 17, no. 6, pp. 425–35, 1984. 
[120] M. Remoissenet, Waves Called Solitons. Berlin, Heidelberg: Springer Berlin 
Heidelberg, 1999. 
[121] E. Hermeling, “Noninvasive Assessment of Arterial Stiffness Should 
Discriminate Between Systolic and Diastolic Pressure Ranges,” Hypertension, 





Physiology of Arterial Waveforms, Sensors, and 
Measurement Methods 
 
This chapter describes the basic cardiovascular physiology principles and mechanics 
that are necessary to understand the concepts of blood flow underlying the arterial 
stiffness assessment. This chapter outlines the following concepts: blood flow from the 
heart, the Windkessel effect in the aorta, the effects of arterial tree dynamics on blood 
flow, and the effects of reflected waves on pressure and flow waveforms. The elasticity 
of the arteries, blood rheumatology, and their complexity inflow will also be described, 
in the context of blood flow and PWV. The methods used to estimate arterial stiffness, 
including arterial waveform morphology, PTT, HRV, and local PU-loop methods, are 
explored and compared across different sensing methodologies. 
2.1 The Cardiovascular Mechanics 
The cardiovascular system’s primary purpose is to transport blood to and from the 
organs, where gaseous and nutrient exchanges occur in tissues, at the cellular level. 
These exchanges occur in a convection fashion, which allows it to overcome massive 
precapillary resistance. Further explanations can be found in the book ‘Computational 
Cardiovascular Mechanics’ [1]. 
The heart works as a mechanical pump, and its circulation system has two 
components, pulmonary circulation and systemic circulation. Pulmonary circulation 
emanates from the right atrium (RA) and right ventricle (RV), where the vena cava 
stores blood before oxygenation by the lungs. Systemic circulation emanates from the 
left ventricle (LV) and the left atrium (LA), which receives oxygenated blood from the 
pulmonary veins, and the LV pumps the blood to the whole body, as shown in Figure 
2.1. The heart pumps blood in a non-continuous manner, into the aorta. The ventricle 
pressure-volume relationship during each beat has four stages: ventricular filling, 
isovolumetric contraction, ejection, and isovolumetric relaxation. The cardiac cycle is 
illustrated in Figure 2.2, using Wigger’s diagram, in which the temporal relationships 





Figure 2.1: Schematic view of the cardiac circulation system [2] 
 
Figure 2.2: Wigger’s Diagram [3] 
2.2 Facts About the Heart and Arterial Flow  
BP and blood flow are generated by the heart, which is essential for transport in a 
closed-loop system. During an average lifetime of 70 years, the human heart beats 
more than 2.5 billion times and pumps approximately 1 million barrels of blood, which 
travels 0.3 billion miles in the arterial tree [4].  
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2.3 The Arterial Tree and Blood Circulation 
Arteries are composed of four layers, the endothelium, elastin, collagen, and smooth 
muscle. The endothelium is a single-cell layer, which regulates the blood for a smooth 
layer. Elastin is the most flexible part of the wall and is a central component of the 
aorta. Collagen is 400 times stiffer than elastin and becomes active at high BP. Smooth 
muscles produce tension via physiological changes and are prominent components of 
the peripheral arteries. The Maxwell artery model can be used to characterise the 
features [5][6], as shown in Figure 2.3 (a-d).  
 
Figure 2.3: The Maxwell Arterial Model [6] 
In this model, ‘E’ represents elasticity, the subscript ‘e’ represents elastin, and ‘c’ 
represents collagen. For double subscripts, ‘s’ represents series and ‘p’ represents 
parallel. ‘N’ represents the number of elements, ′𝜀′ represents strain, and ′𝜎′ 
represents wall stress. Figure 2.3a and b show the low extension and high extension 
of the central wall, respectively, during smooth muscle relaxation. Figure 2.3c and d 
show the low extension and high extension of the central wall, respectively, during 
smooth muscle contraction, and Figure 2.3e shows the peripheral wall. The spring 
represents elastin, the hook represents collagen, and the box with a cross represents 
the smooth muscles.  
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Arteries can be categorised into four categories, based on their sizes: large arteries, 
small arteries, arterioles, and capillaries. In the circulation system, the heart works 
periodically, alternating between high-volume and no-volume blood flow. When BP in 
the LV increases, aortic pressure opens the aortic valves, and blood is ejected into the 
ascending aorta, which is referred to as systole. When LV pressure falls, the aortic 
valve closes and no blood flows from the heart, which is referred to as diastole. The 
aorta connects to arteries, which connect to arterioles and then to capillaries.  
The pressure in the systematic circulation system ranges from 80–120 mmHg in 
healthy adults, under relaxed conditions, whereas the pressure in the pulmonary 
circulation system ranges from 8–25 mmHg. Furthermore, the pressure in the 
pulmonary capillaries ranges from 0–7 mmHg in the systemic arteries. The pressure 
level in the arterial network is shown in Figure 2.4.  
The arterial tree walls dilate and constrict to regulate BP, which are referred to as 
vasodilation and vasoconstriction, respectively. Blood regulation depends on blood in 
the tissues, which passes through the capillaries. The exchange of fluid, gas, nutrients, 
hormones, and other substances occurs in the capillaries. Venules collect the blood 
and transport them to veins, which progressively increase in size, as shown in Figure 
2.5.  
The arterial wall consists of elastic fibres and smooth muscles, which make the arteries 
behave in a viscoelastic manner. When moving from a larger artery to a smaller artery, 
the elastic fibre composition gradually decreases, whereas smooth muscles increase, 
as stated by Ottesen et al. [7]. 
 





Figure 2.5: The circulatory system [8] 
2.4 Windkessel Effect 
In the circulatory system, the aorta is the most prominent artery, which changes the 
heart’s non-continuous flow into a continuous flow. During systole, aortic pressure 
increases, whereas, during diastole, pressure decreases until the next systole. Aortic 
compliance gives the aorta the capacity to hold a large amount of blood, a 
phenomenon that was explained by Otto Franks using the Windkessel (WK) model, 
which is shown in Figure 2.6. 
In its simplest form, the WK is comprised of two parameters: resistance and 
compliance (often known as capacitance), relative to the aorta. Resistance depends 
on the radius of the aorta, whereas compliance depends on the elasticity of the aorta. 
Higher resistance is associated with a higher LV load, whereas higher compliance is 
associated with a lower LV load. 
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In the WK model, the aorta is analogous to a chamber filled with air and attached to a 
pump. The pump fills the chamber with water, which compresses the air and pushes 
the water outside. Similar to how the air pocket can be compressed and 
decompressed by water flow, a similar phenomenon occurs in the aorta due to 
elasticity.  
  
Figure 2.6: Windkessel effect [10] 
2.5 Pulse Wave Velocity 
“The Scientific understanding of the pulse and its application to medicine has at all 
times been dependent on the knowledge of the theory and of physiological 
mechanisms, and on tile availability of methods for its measurements.” The importance 
of the arterial pulse is emphasised in “The Arterial Pulse” by O’Rourke, Kelly and 
Avolio (1992) [11]. 
The accurate estimation of arterial stiffness is known to have great diagnostic and 
prognostic value and has attracted much research attention during recent decades. 
PWV is a non-invasive, straightforward, and reproducible method for the measurement 
of arterial stiffness. PWV ‘is not blood flow velocity’; furthermore, PWV is at least 20 
times faster than blood flow velocity in a healthy subject.  
To understand the concept of PWV, the analogy of shock wave behaviour through 
solids and liquids can be used. Newton’s cradle is an ideal example of the movement 
of a shockwave, as shown in Figure 2.7. When the observer raises the hanging steel 
ball and then releases it, the ball converts potential energy to kinetic energy, hitting 
the other hanging balls. As it strikes, the ball generates a shock wave that moves the 
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last ball, which swings like a pendulum. The movement of the shock wave is a 
thousand times faster and independent of the speed of the first ball. The last ball 
breaks away with a speed similar to that of the first ball when it struck the second ball. 
 
Figure 2.7: Newton’s cradle 
 
Figure 2.8: Three-ball Newton’s cradle, used by Ceanga et al. [12] 
 
Figure 2.9: Velocity impulse diagram [12] 
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Ceanga et al. [12] explained a three-ball Newton’s cradle, using a very small ball 
between two very large peripheral balls, as shown in Figure 2.8, where, ‘m’ = mass, 
‘’ = impulse, ‘’= velocity, ‘i’ = order number, and the subscripts show the numbers of 
the objects. Figure 2.9 depicts the impulse velocity diagrams of the small ball, which 
introduces several micro-collisions that transmit the momentum from one incident 
large ball to the other large ball. 
A tsunami, which can be caused by an earthquake, is an example of applying a similar 
principle to liquids. The tectonic plates under the earth’s crust strikes and generates a 
shock wave under the surface of the sea, causing a tsunami wave. The height and 
magnitude of a tsunami are much larger than those of normal waves. The shock wave 
in this scenario moves differently compared with Newton’s cradle. The transfer of 
energy among solids does not cause the deformation of shape, whereas, for liquids, 
shockwaves move all of the material, according to the principle of conservation of 
momentum, and the behaviour is the same as that observed for Newton’s cradle. 
In a healthy subject, the LV ejection period is 0.35  0.08 ms [13] at 72 bpm and is 
dependent on heart rate (HR). The preload, afterload, and contractile states represent 
40% of the cardiac cycle, whereas the LV relaxes for the remaining time. During each 
LV ejection, 70 ml of blood is pushed into the arterial system in a 70-kg, healthy 
subject. This push results in a tidal wave, which increases the BP to 120 mmHg during 
the LV relaxation period, then reduces the BP until it reaches 80 mmHg. The aorta 
regulates the blood flow, but the effect of the tidal wave can be observed in the arterial 
tree, in the shape of pulses. Continuous heartbeats result in a standing wave in the 
arterial tree, resulting in pulses far from the heart exerting different effects on its 
waveform due to the reflected waves.  
The aorta follows the WK principle, which ensures that blood will flow continuously 
after being released in a non-continuous manner from the LV. Due to LV contraction 
a volume blood ejects into the aorta generates a shock wave which modulates on top 
of blood flow out of aorta and speed of shock incarease as the arterial system gets 
stiffer.  
The heart works periodically; however, the speed of blood flow speed does not change 
in response to pulsation. The elasticity of the arterial tree generates a distension 
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waveform, which transforms kinetic energy into potential energy and results in the 
pulsation phenomenon. 
Waves move faster in solids than in liquids, and the same phenomenon can be 
observed for arterial stiffness, in the form of PWV. A stiffer artery results in higher 
PWV, which eventually results in high BP.  
2.6 Morphology of the Arterial Waveform 
The arterial waveform contains two distinct regions, the rising edge region, called the 
anacrotic region, and the falling edge region, called the catacrotic region. The 
anacrotic region represents the systolic phase, whereas the catacrotic region 
represents the diastolic phase. The dicrotic notch is present in the catacrotic phase, 
and its position is highly reliant on the compliance of the artery, as shown in Figure 
2.10.  
Arterial stiffness can be determined using PWV and pulse contour analysis [14]. The 
myriad of bifurcations generates reflected waves and frequent anastomoses, which 
eventually forms a standing wave. The total reflection results in a notch, which ideally 
occurs in the middle of the catacrotic phase of the waveform, as it moves from systole 
to diastole. The reflection wave travels faster as arteries become stiffer, which can 
result in higher BP, as shown in Figure 2.10, which shows a comparison between 
normotensive and hypertensive reflected waves.  
 
Figure 2.10: The effects of artery stiffness on reflected waves. ‘A’ is normotensive 
and ‘B’ is hypertensive [15] 
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The arterial pulse contour contains haemodynamic information [16] of prognostic 
value, and arterial stiffness can significantly change the morphology of the pulse 
contour. The relationship between the anacrotic phase of the wave and the reflected 
wave can be measured using the augmentation index (AIx). Both large artery stiffness 
and peripheral resistance cause larger wave reflections, which greatly influence the 
AIx [16]. A tonometric device can be used to measure the PWV and AIx and requires 
highly trained operators. Digital volume pulse contour analysis is an alternative to 
tonometric techniques, which uses the second derivative of the raw PPG waveform, 
which is also known as the accelerated plethysmogram (APG), to analyse the 
anacrotic and dicrotic notches, using mathematical remodelling. The second derivative 
fiducial point and derived parameters are closely associated with the distensibility of 
the carotid artery, age, BP, and arterial diseases [17]. 
2.6.1  Augmentation Index (AIx) 
The AIx measures reflected wave perturbations on the systolic pressure waveform. 
The reflected waves moving from the peripheral artery to the central aortic artery result 
in the dicrotic notch. Lower artery compliance is disproportionately associated with an 
increase in systolic pressure, which eventually results in a higher load in the LV. AIx 
is measured as a ratio between systolic peak and tidal crest difference and the systolic 




 ×  100%      (2.1) 
 
Figure 2.11: Peripheral pulse augmentation index (AIx) [18] 
2.6.2  Reflectance Index 
The reflectance index is defined as the temporal difference between the systolic peak 
and the dicrotic peak [19], as shown in Figure 2.12 and Equation 2.2. 
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𝑅𝐼 = 𝛥𝑇      (2.2) 
 
Figure 2.12: Time delay between the arterial waveform peak and the dicrotic notch 
[17] 
2.6.3  Stiffness Index 
The stiffness index is defined as the ratio between the systolic peak and dicrotic peak 




      (2.3) 
 
Figure 2.13: Arterial waveform and fiducial locations [17] 
2.6.4  Large Artery Stiffness Index 
The systolic component is caused by the pressure wave generated by the LV and 
morphological changes as the wave reaches the end of the organ or the distal artery. 
Large artery stiffness index is defined as the ratio between the systolic peak and the 




        (2.4) 
where ‘x’ is the height of the pulse and ‘∆𝑇’ is the time delay, which decreases with 




Figure 2.14: Changes in the augmentation index with changes in subjects’ ages [21] 
2.7 Accelerated Plethysmogram (APG) 
The acquisition of PPG waveforms is simple, but the detection of the inflexion point is 
questionable on this waveform. Researches have used the first and second derivatives 
to facilitate the interpretation of the features [16], which has been quite successful. 
The APG analysis has roots in Eastern medicine, where the pulse has been greatly 
important as a diagnostic tool, and most of this work has been based in Japan. Inuma 
et al. [22] described the APG waveform morphologies for various subjects, as shown 
in Figure 2.15, which can be stratified as follows: (A) represents good blood circulation, 
indicating healthy subjects; (B) represents good circulation but deterioration has 
begun; (C) represents poor circulation, which can be caused by cold sensitivity and 
other factors, including atherosclerosis; (D–G) represent terrible circulation, which can 
be due to a variety of diseases, including cerebrovascular diseases, breast cancer, 




Figure 2.15: Accelerated PPG, categorised by patient categories [24] 
The APG fiducial point ratio increase/decrease provides information regarding arterial 
stiffness [16], can be used to segregate hypertensive subjects [23], correlates with the 
Framingham score [25], pharmacological effects [16], left ventricle afterload [26], 
vascular age [27], and sympathetic response [28], and is closely related to age. The 
APG waveform provides information regarding blood circulation, which can be used to 
differentiate cerebrovascular, ischemic, and tumour-related diseases [22]. Nousou et 
al. [23] have developed a self-organising map system to adjust the APG peaks, to 
classify peaks correctly.  
2.7.1  First Derivative 
The first derivative is the least commonly used derivative in the literature [21] and is 
most often used to detect the diastolic parameter, when the first derivative is the 
closest derivative, or to determine the zero-crossing point. The parameter ′∆𝑇′ 
represents the time necessary for the pressure wave to go from the left ventricle to the 
peripheral artery and back to the heart, as shown in Figure 2.16, and can be calculated 




Figure 2.16: First derivative fiducial points [17] 
2.7.2  Second Derivative 
The second derivative of PPG is considered to be more useful for the interpretation of 
signal morphology. In the second derivative, four waves are in the anacrotic phase 
and one is in the catacrotic phase, as follows: (1) the a-wave is the early systolic 
positive wave; (2) the b-wave is the early systole negative wave; (3) the c-wave is the 
late systole re-increasing wave; (4) the d-wave is the late systole re-decreasing wave; 
and (5) the e-wave is the dicrotic notch [17]. The height of each wave is measured 
from the baseline, resulting in positive values above the baseline and negative values 




Figure 2.17: Second derivative fiducial points [17] 
2.7.2.1 The Ratio of b/a 
Takazawa et al. [16] stated that the b-wave to a-wave ratio increases as arterial 
stiffness increases and also increases with age. Imanaga et al. [29] stated that the 
ratio represents the local vascular distensibility, showing changes in the artery caused 
by distensibility diseases, such as atherosclerosis. Aiba et al. [30] showed that the 
negative value of this ratio decreases as exposure time to lead (metal) increases and 
significant changes were observed in subjects who were exposed to lead for more 
than five years in their respective working environments. Nousou et al. [23] were able 
to independently distinguish between hypertensive and healthy subjects using ratio 
values. Otsuka et al. [25] demonstrated that this ratio was favourably correlated with 
the Framingham score, which is an independent factor for predicting CVD patient. 
Baek et al. [26] showed that this ratio increases with age.  
2.7.2.2 The Ratio of c/a 
Takazawa et al. [16] showed that the c-wave to a-wave ratio decreases as arterial 
stiffness decreases and that it decreases with age. Nousou et al. [23] showed that this 
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ratio was independently able to distinguish between hypertensive and healthy 
subjects. Baek et al. [26] showed that this ratio decreases with increasing age. 
2.7.2.3 The Ratio of d/a 
Takazawa et al. [16] showed that the d-wave to a-wave ratio reflects a decrease in 
arterial stiffness, and Baek et al. [26] showed that this ratio decreases with age. The 
negative value of this ratio is useful for the evaluation of vasoactive agents in the 
bloodstream. 
2.7.2.4 The Ratio of e/a 
Takazawa et al. [16] demonstrated that the e-wave to a-wave ratio increases with 
decreased arterial stiffness, and Baek et al. [26] showed that this ratio decreases with 
increasing age. 
2.7.2.5 The Ratio of (b – c – d – e)/a 
Takazawa et al. [16] demonstrated that examining the ratio between the total 
difference among the b–e-waves and the a-wave increases with age and can be useful 
for describing vascular ageing, which can be used as a screening tool for 
atherosclerosis. Kimura et al. [27] used this ratio to measure vascular age, using a 
multiplicative factor of 45.5 and an additive factor of 65.9.  
2.7.2.6 The Ratio of (b – e)/a 
Baek et al. [26] demonstrated that even when the c-wave and d-wave are missing, the 
ratio comparing the difference between the b–e-waves and the a-wave may be able to 
measure vascular age. Inuma et al. [22] classified the APG, based on different levels 
of blood circulation, as shown in Figure 2.15, which was able to clearly define the 
cases examined by Baek et al. [26]. 
2.7.2.7 The Ratio of (c + d – b)/a 
Inuma et al. [22] demonstrated that the ratio between the value calculated as the ratio 
between (c + d – b) wave and the a-wave can provide a comprehensive ageing index, 
which increases with age, especially in cases of bad blood circulation or cold 
sensitivity. 
2.8 Pulse Transit Time 
The PTT refers to the time necessary for a pressure pulse to travel between two distant 
points on an arterial tree. For a fixed distance, the travel time depends solely on the 
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arterial condition. Stiffer arteries are associated with shorter travel times for pressure 
pulses, and vice versa. PTT can be a difficult parameter to measure as the arterial tree 
can have different artery compositions at different sites. Conventionally, PTT is 
measured at the carotid and the femoral (C&F) arteries and has been demonstrated 
to be a good predictor of CVDs. The C&F PTT parameter is highly dependent on 
subject height and provides gives information for the aortic artery. The C&F PTT is 
based on a component of the arterial network, which has a mixed composition for large 
arteries because the measurement is taken at two sites and two different branches. 
The aortic arch bifurcates into branches, and the distance between the measurement 
sites is not directly equivalent to the distance between the measurement site and the 
arch. This measurement technique requires a tonometric device, with the subject in 
the supine posture. PTT techniques used at the distal arteries (e.g. radial and digital) 
use PPG and PVDF sensors [6], which are suitable for wearable applications.  
2.9 Pressure-Volume Loop 
PTT techniques require two sensors, at two distant positions, to acquire data. In 
contrast, The PU-loop method can be used to determine the PWV from a single 
measurement location. The most significant advantage of the PU-loop method the 
ability to assess arterial stiffness from a single measurement point. The single-point 
assessment provides a direct relationship with the arterial site, which can help assess 
atherosclerosis in a specific area or facilitate the assessment of a specific area both 
before and/or after surgery. 
Using this technique, the pressure and volume waveforms are acquired 
simultaneously, at a single location. In traditional clinical practice, the PU-loop is 
measured invasively, by inserting a catheter into a carotid or femoral site. In the heart, 
the LV PU-loop can be measured to determine ventricle enlargement or LV 
hypertrophy. The PU-loop can be used to assess the arterial condition after graft 
surgery and bypass surgery [31].  
This technique can be very suitable for wearable technology because it requires only 
a single location. This technique can be used for the fusion of two waveform datasets. 
This technique was investigated for the measurement of PWV using a non-invasive 
method, as explained in Chapter 5.  
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2.10 Heart Rate Variability  
HRV has prognostic value for cardiovascular morbidity and is known to be a precursor 
for hypertension and other CVDs. HRV is a physiological phenomenon and describes 
the measure of variability between beat to beat intervals. HRV is a predictor of 
autonomic balance between the sympathetic and parasympathetic modulation of the 
HR. An increase in sympathetic activity and a decrease in the parasympathetic 
response are predictors of cardiac mortality [32] associated with diseases, such as 
myocardial infarction, stroke, and heart failure. Reduced HRV is a predictor of 
parameters that increase the Framingham risk score, such as hypertension, diabetes, 
high cholesterol, smoking, and increasing age [32].  
Sympathetic activity increases HR during exercise and other exertion activities. 
Parasympathetic activity decreases the HR during condition such as rest and sleep. 
These two systems regulate the HR in circadian cycles, increasing during the day to 
respond to daily tasks and decreasing at night while resting or sleeping. In a healthy 
subject, HR changes continuously and dynamically, in addition to following circadian 
rhythms.  
2.10.1 Time Domain 
The time-domain measurement is the simplest and most useful analysis method and 
is the least prone to noise. This analysis quantifies the variability associated with 
interbeat intervals and uses statistical measurements [33]. The primary parameters 
are as follows: 
• SDNN: Standard deviation of normal-to-normal (NN) intervals 
• RMSSD: Root mean square of successive NN intervals 
• NN50: Number of adjacent NN intervals that differ from each other by 50 ms 
• pNN50: Proportion of adjacent NN intervals that differ from each other by 50 
ms 
• HR 
The SDNN is the gold standard for CV risk stratification, and values below 50 ms 
indicate unhealthy subjects, whereas 50–100 ms indicates compromised health and 
above 100 ms indicates healthy subjects. Individuals with SDNN values of at least 100 
ms have a 5.3-fold lower chance of heart attack than individuals with SDNN values of 
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50 ms or lower. NN50 and pNN50 require an epoch of 2 min. RMSSD estimates 
vagally mediated changes in HRV, which are a source of parasympathetic activity [34]. 
2.10.2 Frequency Domain 
In the frequency domain analysis, the sum of the sinusoids represents the time series. 
The analysis measures the distribution of power in four frequency zone [33], as 
follows:  
• Ultra-low frequency (ULF) band, ranging up to 0.003 Hz and below  
• Very low frequency (VLF) band, ranging from 0.003–0.04 Hz 
• Low-frequency (LF) band, ranging between 0.04–0.15 Hz  
• High-frequency (HF) band, ranging between 0.15–0.4 Hz 
The distribution measurement schemas are categorised as follows: 
• The ratio of LF to HF power  
• The power of frequency bands, in standard units 
• The absolute power of the frequency band, in ms2  
The stratification methods for the frequency band can be performed using Fast Fourier 
transform or autoregressive modelling. Because the circadian rhythm is the primary 
driver of the ULF band, HRV must be recorded for 24 hr. ULF can show distinct regions 
associated with different psychiatric activities during a 24-hr recording. VLF is strongly 
correlated with causes of mortality and shows a stronger correlation then the LF and 
HF zones. The sympathetic activity has significant influences on the amplitude and 
frequency of the VLF band. LF is primarily reflected by baroreceptor activity but not by 
a cardiac sympathetic intervention. LF requires a minimum recording of 2 minutes for 
analysis. HF represents the respiratory-induced changes in HR, which can vary in 
neonates and adults. HF activity increases at night and is correlated with stress, 
anxiety, and panic-like feelings. The LF/HF ratio provides information regarding the 
sympathetic and parasympathetic activity ratio. 
2.10.3 Nonlinear Domain 
The nonlinear domain analysis quantifies the unpredictability of the interbeat interval 
time series, and the non-linear domain parameters are as follows [33]:  
• Poincaré plot standard deviation perpendicular to the line of identity (SD1) 
• Poincaré plot standard deviation along the line of identity (SD2) 
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• The ratio of SD1 to SD2  
• Sample entropy, which measures the regularity and complexity of a time series 
• Approximate entropy, which measures the regularity and complexity of a time 
series 
The nonlinearity analysis correlates the frequency and time domain measurements 
when they result from the same processes, such as post-myocardial infarction. A 
Poincare plot is a scatter plot of the distance between an R-R interval to its previous 
interval. SD1 predicts DBP and the difference in HR and requires 5 min of HRV 
recording. SD2 reflects the baroreflex sensitivity and can be calculated based on either 
short-term or long-term HRV recordings. SD1/SD2 provides similar information to 
LF/HF, with the assumption that LF is the result of sympathetic activity and HF is the 
result of parasympathetic activity. Sample entropy provides a less-biased single 
regularity and complexity compared with the time series. In contrast, approximate 
entropy provides a similar single regularity and complexity as a time series. 
2.10.4 Time-Frequency Analysis 
The time-frequency analysis provides the temporal evolution of the spectrum, allowing 
time and frequency information to be viewed simultaneously [33]. The autoregressive 
Lomb-Scargale periodogram and wavelet transforms to calculate the spectrogram. 
The same parameters used in the frequency domain analysis are used, such as the 
peaks and percentages of ULF, VLF, LF, and HF bands. 
In the windowed-periodogram method, larger windows are separated into smaller 
windows, which can be overlapping, to determine power spectral density (PSD). The 
two-dimensional plotting of the PSD along the time and frequency axis produces a 
spectrogram. A continuous wavelet transform is a useful tool for the time-frequency 
analysis on smaller-windowed periodograms.  
2.11 Sensing Methodologies 
2.11.1 Photoplethysmogram - PPG 
The word plethysmogram is a combination of two Greek words, ‘plethysmos’, meaning 
increase, and ‘gram’, meaning writing [35]–[37]. Over the last century, 
plethysmograms have evolved, and different variants measure variations in blood flow 
volumes, using water- [38]–[42], air- [43], [44], or mercury-filled [45]–[50] cuffs, which 
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are strapped to an organ. With the advent of the digital era, techniques have evolved 
to include impedance- [51]–[53] and photovoltaic-based [54]–[65] blood flow 
measurements. In 1938, Hertzman discovered a relationship between backscattered 
light and volumetric blood flow, a phenomenon known as PPG [9]. PPG consists of a 
photovoltaic sensor [36], which measures changes in volumetric blood flow in the 
microvascular bed of tissues against incident light. PPG devices show high sensitivity, 
reliability, and reproducibility. They are easy to use, simple to set up, convenient, and 
economical, representing a non-invasive and less intrusive form of sensor. PPG 
devices have been widespread in clinical practice, on an everyday basis, in primary 
and intensive health care units, to measure blood oximetry and HR.  
PPG waveforms are morphologically similar to BP waveforms, providing vital insights 
into the cardiovascular system. Skin, bone, pigment, and arterial and venous blood 
flow absorb incident light, which can be measured using two methods. In the 
transmissive method [6], the source of light is within the line of sight of the receiver. In 
the reflective method [23], [29], [36], the source of light illuminates the area, and the 
bone reflects the light to the receivers.  
The waveform consists of an alternating current (AC) component and a direct current 
(DC) component, as shown in Figure 2.18. The AC component is the result of 
volumetric changes in the pulsating blood flow through an artery, in which the main 
component of light is absorbed by haemoglobin [66]. The DC component depends on 
the tissue’s average blood volume in the arteries and veins, skin, bone, and other 
tissues. The waveform provides vital biomarker information regarding arterial blood 
flow and HR.  
 
Figure 2.18: Wearable Photoplethysmography Sensors - Past and Present [67] 
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PPG sensing follows the Beer-Lambert–Bouguer law [68]: 
𝐼(𝜆) =  𝐼0 exp [−𝜇𝑎(𝜆)𝑐𝑑]    (2.5) 
where ′𝐼(𝜆)′ is the intensity of light (lux), ′𝐼0′ is the intensity of incident light (lux), ′𝜆′ is 
the source wavelength (cm), ′𝜇𝑎′ is the extinction coefficient or absorptivity of the 
substance (L/mmol*cm), ‘c’ is the concentration of the absorbing substance, which is 
constant in the medium (mmol/L), and ‘d’ is the optical path length of the medium (cm). 
The skin consists of the epidermis, dermis, and subcutaneous tissue layers, which 
contain capillaries, arterioles, and arteries. The penetration depth of the light source 
depends on the wavelength of the source. Commonly used light source wavelengths 
include 440 nm (green), 660 nm (red), and 960 nm [infrared (IR)] [35], [36], [67], [69]–
[72], and the penetration depth increases as the wavelength increases, from 300 nm 
to 1,100 nm. The augmented depth for wavelengths and skin layers are shown in 
Figure 2.19. The IR wavelength is less sensitive to oxygenation in the blood and 
produces a more stable signal [35]. The IR wavelength is most commonly used for 
cuffless BP estimations.  
The contact pressure of the sensor considerably changes the waveform and derives 
information [73]. Contact pressure is required to increase the amplitude, which is 
relative to the wavelength, and is pronounced in shorter wavelengths [67], [71], [74]–
[76]. Reduced pressure avoids discomfort and tissue damage.  
 
Figure 2.19: A schematic diagram of the finger layers and the penetration depth of 
the light source [77] 
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2.11.2 Ballistic Pulse Pressure – BPP 
Volume changes in the limbs have been important for clinical and physiological 
assessments. Limb girth variations are due to arterial blood flow waveform which is 
directly proportional to a pressure wave in the blood flow stream. The systolic 
amplitude is directly proportional to vascular distensibility [81].  
This mechanical distortion, which is caused by arterial distension, has been the focus 
of research since the late 18th century. The methods devised by Schafer et al. [78], 
and then adapted by Ahlborh et al. [79], used a rigid fluid-filled jacket that was strapped 
around the limb and attached to a scale, to allow the changes in the enclosed limb 
volume or the distension waveform to be observed. In 1949, mercury in a rubber 
resistance strain gauge was used to measure the girth of the limb. A representative 
system, consisting of two gauges strapped around the limb, is shown in Figure 2.20. 
 
Figure 2.20: Resistive gauges strapped on limbs [80] 
The piezoelectric sensor is a piecewise, continuous electromechanical sensor that 
measures changes in mechanical displacement/pressure and produces a change in 
the electrical form. Lee et al. [83] formulated the classical equation for a thin laminate, 
with a piezoelectric effect. On a thin laminate, the displacement is characterised by 




Figure 2.21: Laminated model of a composite plate with an electrode surface [84] 
In Figure 2.21, ′𝑢0′ is the displacement in the x-axis, ‘𝑣0′ is the displacement in the y-
axis, and ‘a’ is the length and ‘b’ is the width of the sensor, which is negligible 
compared to the orthogonal axis deflection, ‘w’, in the z-axis. The deformation 
produces a charge ′𝑞𝑟(𝑡)′ [83], defined as follows: 
 






    (2.6) 














      (2.7) 
𝐹𝑟(𝑥, 𝑦) = {
1 𝑖𝑓(𝑥, 𝑦) 𝑖𝑠 𝑤𝑖𝑡ℎ𝑖𝑛 𝑡ℎ𝑒 𝑟𝑡ℎ 𝑠𝑒𝑛𝑠𝑜𝑟 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒
0 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
    (2.8) 
where ′𝑒31
0 ′, ′𝑒32
0 ′, 𝑎𝑛𝑑 ′𝑒36
0 ′ are piezoelectric [(charge/area)/strain] constants, ′𝑃0(𝑥, 𝑦)′ 
is directional polarity, ′𝑧?̅?′ is the distance from the geometric centre of the ‘rth’ sensor, 
and ‘N’ is the number of piezoelectric sensors [84]. 
The waveform that is measured by a piezoelectric sensor is the BPP waveform. The 
BPP waveform contains information regarding arterial diameter changes caused by a 
pressure wave [82]. BPP measures the distention waveform, which is the result of 
transmural pressure on the elastic boundaries of the artery. 






 r>>s      (2.9) 
where ′𝜎′ is circumferential tension (Pa), ′𝑝𝑖′ is internal pressure (Pa), ‘r’ is the vessel 
radius (m), and ‘s’ is wall thickness (m).  
BPP is related to the distension waveform according to Hooke’s Law, which is stated 
as: 
𝜎 = 𝐸. 𝜖      (2.10) 
where ‘E’ is the elastic modulus (N/m2) and ′𝜖′ is the strain (dimensionless). 
The effects of arteriosclerosis, aortic stenosis, and aortic insufficiency have been 
exemplified by the use of a piezoelectric PVDF sensor at the radial artery [82], as 
shown in Figure 2.22. 
 
Figure 2.22: Normal (Left to right), arteriosclerosis, aortic stenosis, and aortic 
insufficiency waveforms recorded using a piezoelectric sensor [82] 
2.12 Summary 
This chapter provides a background of cardiovascular mechanics, which are very 
important to fully understand and extract information from an arterial waveform. Blood 
flow originates from the heart, moving through the arterial tree, and back into the heart, 
in a closed-loop system. Then, the arterial tree affects the blood flow waveform, based 
on changes in arterial composition and area. The WK phenomenon in the arterial tree 
explains the slow fall in aortic pressure compared with the ejection of blood flow from 
the LV. The WK model reduces the load on the heart and the end organs, which is 
very important for the cardiovascular system. Then, the principle of PWV was 
explained, the most important phenomenon necessary to understand the stability of 
blood flow in a closed-loop, pulsating system. PWV represents the oldest method for 
the measurement of arterial stiffness, which measures speed, based on an Eulerian 
frame of reference. The importance of arterial waveform morphologies and their 
related stiffness indexes were described, which are indicators of the severe effects on 
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the cardiovascular system caused by arterial stiffness. Next, the APG analysis was 
described, which is a state-of-the-art signal-processing method that can extract hidden 
information from an arterial waveform. APG indexes can quantify arterial stiffness and 
predict adverse effects. This chapter also developed the background of HRV, PTT, 
and the PU-loop, which are key methods for the validation of arterial waveforms 
because of their trackability, consistency, and fusion across the different 
morphologies. Finally, the working principles of PPG and BPP sensors, which are the 
sensors under comparison, were described, including their sensing methodologies 
and associated waveforms. The BPP sensor was compared against the state-of-the-
art PPG sensor and validated against the HRV, PTT, and PU-loop techniques, based 
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Mathematical Derivation of Arterial Flow and its 
Relationship with Haemodynamic Parameters 
 
This chapter aims to develop and describe the mathematical reasoning used for the 
sensing and measuring of the distention waveform. Then, explanations for the 
physiological information, interpretations, and related prognostic values are provided. 
In the first derivation, the pressure-flow relationship is derived from the Navier-Stokes 
equation, which is central to this study. The second derivation develops the pulse-
wave propagation relationship with arterial stiffness. The third derivation develops the 
arterial stiffness relationship with BP. The fourth derivation develops the relationship 
between the pulse waveform and haemodynamic parameters, which serves as the 
basis for the waveform analysis. Lastly, the fusion of the data into a PU-loop 
relationship is derived. 
3.1 The Relationship Between Arterial Flow and Pressure 
Waveform 
The Navier-Stokes equations [1] describe the motion of incompressible Newtonian 
fluids. These equations have a complex solution, but the equations can be simplified 















































































 is the pressure force in the x direction, 𝜌𝑔𝑥 is the weight of the fluid in the x 
direction, and the corresponding variables refer to the same information in the ‘y’ and 
‘z’ directions. The second partial derivative represents the viscous forces, in their 





































Simplifying the equations using Poiseuille flow [2], which describes the velocity of the 






[𝑟2 − 𝑅2]       (3.5) 
Where ′𝜌′ is the liquid density, ′𝜇′ is viscosity, ′𝑣′ is kinematic viscosity (ratio between 
density and viscosity), ′𝑃′ is pressure, ′𝑅′ is the external radius of the tube, ′𝑟′ is the 
internal radius of the tube, ′𝑙′ is the length of the tube, ′𝜔′ is the longitudinal velocity of 
the liquid, and ‘𝑓 =
𝑛
2𝜋
′ is the frequency, equal to the HR of the subject. 
The Poiseuille flow is steady and uniform over a laminar cross-section, and axially is 
symmetric with a cylindrical tube, which makes 
𝜕𝜔
𝜕𝑡
= 0 , 
𝜕𝜔
𝜕𝑥
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= 0     (3.7) 
Womersley et al. [3] expressed the arterial pulse pressure gradient as a periodic 




      (3.8) 







𝑛=0 ]     (3.9) 
where     
  𝑎𝑛 = 𝐴𝑛 + 𝑖𝐵𝑛  
Using Euler’s formula, the Fourier coefficients can be represented as follows:  
𝜕𝑃
𝜕𝑥
= 𝐴0 + ∑ 𝐴𝑛 cos(𝑓𝑛𝑡)
𝑁
𝑛=1 + ∑ 𝐵𝑛 sin(𝑓𝑛𝑡)
𝑁
𝑛=1     (3.10) 
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Velocity changes periodically, over the period defined as: 
𝜔 = 𝑢(𝑟)𝑒𝑖𝑓𝑛𝑡     (3.14) 















       (3.15) 
Equation 3.15 can be transformed into a Bessel zero-order differential equation, using 
the fact that: 
−𝑖 = 𝑖3        (3.16) 
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The solution for the general Bessel function is as follows: 










)    (3.20) 
The term ′𝑌0′ must be discarded, as ′𝑢𝑛(𝑟)′ is finite in the centre of the tube. Because 
equation 3.17 is not in homogenous, a simple solution can be stated, as follows: 
𝑢𝑛(𝑟) = 𝑐3      (3.21) 
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      (3.24) 
The solution is:  
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− 1]      (3.27) 
Adding the steady flow velocity ′𝑢0′ results in the following: 
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𝑢(𝑟) = 𝑢0 ∑ 𝑢𝑛(𝑟)
∞
𝑛=1      (3.28) 
By integrating velocity over a differential area, through the cross-sectional area of the 
tube, the flow rate becomes: 
𝑄 = 2𝜋 ∫ 𝑢(𝑟)𝑟𝑑𝑟
𝑅
0
      (3.29) 




(𝑟2 − 𝑅2)      (3.30) 




𝜋𝑅4     (3.31) 
which is Poiseuille’s formula, replacing ′𝑢(𝑟)′ and using the fact that: 
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      (3.33) 
The solution, in terms of the Fourier series, becomes: 
𝑄 = 𝑄0 + ∑ 𝑄𝑛
∞
𝑛=1       (3.34) 
Womersley solved the equation using the Bessel function in the 19th  century, but 
computation is not the focus of this article, in which it is used as follows:  
𝐽0 (𝑥𝑖
3
2⁄ ) = 𝑀0(𝑥)𝑒
𝑖𝜃0     (3.35) 
𝐽1 (𝛼𝑖
3
2⁄ ) = 𝑀1𝑒
𝑖𝜃1      (3.36) 
Using the real part of ′𝑒𝑖𝑓𝑛𝑡′ is ′𝑀𝑛 cos(𝑓𝑛𝑡 + 𝜙) ′, where ′𝑀𝑛 =  √𝐴2 + 𝐵2 = |𝑎𝑛|′. 







sin(𝑓𝑚𝑡 + 𝜙 + 𝜖10)     (3.37) 
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The graph in Figure 3.2 depicts the pressure gradient ‘P’, juxtaposed with the flow rate 
‘Q’, showing the phase-lag between the two curves [4]. 
 
Figure 3.2: Flow rate 'Q' lags the pressure gradient 'P' [3][4] 
3.2 Pulse Wave Propagation  
Assuming an indefinitely long, isolated tube, through which an inviscid (non-viscous) 
liquid flows, the wave amplitude is small and has a long wavelength compared with 
the tube radius, where the slope of the wall deformation is less than one (< 1).  
For simplicity, a one-dimensional flow can be used. Consider a small fluid element, in 
which an increase in pressure produces an increase in area, as shown below: 
 
Figure 3.3: Change in pressure produces a change in the area of the liquid 
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Linearising the equation by assuming velocity, derivatives of the pressure difference 














= 0       (3.41) 
Taking the derivative of the equation, and equating for ′
𝜕𝑢
𝜕𝑡𝜕𝑥








       (3.42) 
Because the pressure in a thin wall tube is based on solid mechanics, the following 










]     (3.43) 
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This equation is the Moen-Korteweg equation [4], which states the relationship 
between PWV and arterial distensibility. Where ‘E’ is Young's modulus of the arterial 
wall, ‘h’ is the wall thickness, ′𝑎0′ is the arterial diameter and ‘ρ’ is the blood density.  
3.3 PTT Relationship with BP 
PTT represents the time delay of an arterial pulse between two spatially separated 
Eulerian frames of references on an artery. The PTT relationship with PWV can be 




      (3.49) 
where ′∆𝑋′ is the distance between two Eulerian points of references. The Moens-




      (3.50) 
where ‘E’ is the arterial Young’s modulus (kg/ms2), ‘h’ is the thickness of the artery 
(m), ‘r’ is the artery inner radius (m), and ‘𝜌′ is the blood density (kg/m3). Young’s 
modulus [5] of a material can be described as follows:  
𝐸 =  𝐸0𝑒
𝛼𝑃     (3.51) 
where ′𝐸0′ is Young’s modulus at zero pressure (Kg), ‘P’ is arterial pressure (mmHg), 
and ′𝛼′ is a fitting coefficient (1/mmHg). By solving equations 3.49, 3.50, and 3.51, 










ln(𝑃𝑇𝑇)   (3.52) 
The mean arterial pressure or transmural pressure is directly proportional to ‘PTT’, 
which translate to the basis of cuffless BP measurement methods. 
3.4 Arterial Waveform Relationship with a Haemodynamic 
Parameter 
The heart pumps blood in a non-continuous manner through the aorta, which works 
under the WK principle [6], analogous to the resistor-capacitor parallel circuit [7], is 
shown in Figure 3.4 which takes account for compliance (cm3/mmHg) and total 
peripheral resistance (mmHg x s/cm3) of an artery . The compliance of an artery allows 
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volumetric expansion of the artery due to sudden release of blood and compliance 
varies in the arterial tree. The geometry of artery results in total peripheral resistance, 
smaller the artery higher the resistance. The valve resistance ‘r’ is taken as constant 
due to the rapid opening and closing operation. The propagation of pulse wave 
depends on the elasticity of the arteries; stiffer arteries result in higher PWV. This 
relationship is described in the Moens-Korteweg equation (Equation 3.47). 
 
Figure 3.4: 3-element Windkessel model 
The Kirchhoff current and voltage law equations for the model are as follows: 







     (3.54) 
where the arterial flow parameters analogous to electrical model parameters are as 
follows: ‘P(t)’ is aortic BP in mmHg, ‘I(t)’ is blood flow from the heart in cm3/s, ‘r’ is an 
aortic blood flow resistance, in mmHgs/cm3, ′𝑃𝑐(𝑡)′ is aortic compliance in cm
3/mmHg, 
‘C’ is arterial compliance in cm3/mmHg, and ‘R’ is the systematic arterial system 
peripheral resistance in mmHgs/cm3.  
By using a state-space canonical representation and the Laplace transform, the 





+ 𝑟     (3.55) 
The Joukovsky equation states that changes in flow are directly proportional to 
changes in pressure across a wavefront [8]. The relationship between pulse pressure 
and PWV is described as follows: 
𝑃𝑃 = 𝜌𝑣0𝑃𝑊𝑉     (3.56) 
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where ‘PP’ is pulse pressure and ′𝑣0′ is the blood velocity of the heart cycle, which is 





8 × 𝑆𝑉 ×𝐻𝑅
𝜋 𝑑²
     (3.57) 
where ‘HR’ is HR, ‘SV’ is stroke volume, and ‘d’ is the diameter of the artery. By 
replacing the values in equation 3.56, using equation 3.57:  
𝑃𝑃 =





     (3.58) 
The pulse pressure waveform is dependent on elasticity, diameter, HR, and stroke 
volume. Pulse pressure is the pulse height of an arterial waveform, which is the value 
metric difference between the systolic and diastolic peaks, which inherit hemodynamic 
characteristics [9]. Waveform analysis can demonstrate the outcomes of 
hemodynamic parameters and arterial stiffness indices. 
3.5 Pressure-Volume Loop – Data Fusion 
Forces on fluids can be calculated by Newton’s second law [10] of motion, which states 
that the acceleration ‘a’ of an object is directly proportional to the magnitude of force 
‘F’ in the same direction and is inversely proportional to the mass ‘m’ of an object, 
which can be shown as: 
𝐹 = 𝑚𝑎      (3.59) 
In our case, if pressure terms are used, then force can be presented as a change in 
pressure on the area. The change in momentum can represent the mass flow rate. 
Therefore, the equation is as follows: 
𝑑𝑝 𝐴 = 𝐶𝜌 𝐴 (𝑢𝑖 − 𝑢0)        (3.60) 
Simplifying the equation produces the Joukowsky equation [11]: 
∆𝑝 = 𝐶 𝜌 ∆𝑣        (3.61) 
Velocity accounts for arterial stiffness, which can be measured by modifying Hooke’s 
law as follows: 









       (3.62) 
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where ‘ρ’ = blood density, ‘K’ = bulk modulus of fluid, ‘E’ = Young’s modulus, ‘e’ = wall 
thickness of the pipe, and ‘D’ = artery diameter. 
3.6 Summary 
This chapter derives the mathematical relationships between the arterial waveform 
and the haemodynamic parameters, to explain the core principles that underly this 
research study. First, the Navier-Stokes equation was used to derive the relationship 
between blood flow and the pressure waveform, highlighting the differences between 
the sensing methodologies used for PPG and BPP waveforms. The classical 
derivation of the Womersley equation showed the phased lag between the flow rate 
and pressure gradient, which is a pivotal focus of using the BPP sensor in this research 
study. Second, the mathematical derivation of PWV, which states the Moen-Korteweg 
equation, was performed to describe the relationship between PWV and arterial 
stiffness parameters. Third, a derivation between PTT and BP was shown, which is 
the sole driving force for cuffless BP measurements, stating the direct relationship 
between these parameters. Fourth, a derivation between the morphology of the arterial 
waveform and the haemodynamic parameters was shown, to define the relationship 
between the arterial stiffness indexes and their effects on the cardiovascular system. 
Lastly, the Joukowsky equation was used to explain the use of the PU-loop to verify 
the PPG and BPP sensors. This chapter provided the mathematical reasoning for the 
study, the relationship between the haemodynamic parameters and cuffless BP 
measurement techniques, the direct effects of stiffness on BP waveforms, the 
importance of morphological indexes, and a synthesis of all of this information was 
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Experimental Setup, Signal Processing, and 
Statistical Analysis 
This chapter describes the experimental setup and methodologies that were used to 
achieve the specific aims and objectives of the study and to prove a hypothesis 
regarding the potential use of a ballistic pulse pressure (BPP)sensor. The hypothesis 
consists of three components: 1) the Polyvinylidene fluoride (PVDF) sensor can 
measure arterial distention waveforms, BPP waveform, which can electromechanically 
track the beat-to-beat changes associated with HRV; 2) the BPP sensor methodology 
collects richer, less-skewed raw data than a Photoplethysmogram (PPG) sensor; and 
3) the combination between a BPP and a PPG sensor can form a pressure volume 
loop (PU-loop). This chapter first explains the acquisition platform and the integration 
of commercial, off-the-shelf components, and then explains the data collection 
environment, the study protocol, and the signal processing utilisation, in addition to the 
validation of the platform against various existing gold standards. 
4.1 Materials and Methods 
4.1.1 Acquisition Units 
The Biopac MP36R unit (Biopac System, USA) was used for the simultaneous 
acquisition of signals. The acquisition device is comprised of four synchronised 
acquisition channels, which digitise data, at a sample rate of 1 kHz, with a resolution 
of 24 bits, in real-time. The acquisition device is serially connected to a PC (Windows 
10 OS), through AcqKnowledge 4 software, which facilitates data visualisation, 
analysis, and export.   
4.1.1.1 The Electrocardiogram Sensor 
The electrocardiogram (ECG) signal was captured, and its R-peak provided a 
reference location for the cardiac cycles for all arterial waveform. Three electrodes 
were placed proximally (i.e. on the left shoulder, right shoulder, and at the pelvis) to 
capture an Einthoven lead-I, to view lateral wall of left ventricle, signal configuration, 
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as shown in Figure 4.1. The chest area provides a stable anchoring position for the 
ECG signal, which limits noise and motion artefacts. Before placing the hydrogel 
electrodes, the skin of a subject was cleaned with an alcoholic swipe, and hair was 
removed, to ensure good surface contact. Biopac SS2LB leads were used to capture 
the data on channel 1 of the Biopac MP36R unit.  
 
Figure 4.1: Einthoven’s triangle, for ECG electrode placement on the human chest 
4.1.1.2 The PPG Sensor 
A 960-nm wavelength photodiode was used to illuminate the finger area, and blood 
flow changes were captured by a photodetector, which corresponded to the optical 
absorption of the volumetric blood flow. A wavelength of 960 nm achieves the highest 
depth into the hypodermis layer [1], which, in turn, can obtain a response from the 
radial indics artery, at the distal phalanx in the index digit. The reflectance sensing 
technique provided sufficient backscattering for the experiment. The skin of the subject 
was cleaned with a non-alcoholic swipe before the sensors were placed on the finger. 
Biopac SS4LA leads were used to capture data on channels 2 and 4 of the Biopac 
MP36R unit. 
4.1.1.3 The BPP Sensor  
PVDF piezoelectric sensors were used and placed on the index finger, to measure the 
distension waveform of the radial indics artery. The measured waveform is generated 
by the pulsating blood flow and referred to as ballistic pulse pressure (BPP). PVDF 
piezoelectric sensors (Measurement Specialist Ltd., USA) were used, and their 
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outputs were interfaced with an amplifier (Piezo Film Lab amplifier by Measurement 
Specialist). The surface of the sensor was insulated with electrostatic tape. The 
settings of the sensor amplifier are shown in Table 4.1. The output of the amplifier was 
interfaced with an SS9LA lead, through a BNC cable, to channels 1 and 3 of the Biopac 
MP36R unit. The sensor was wrapped on top of the PPG sensor fixture and strapped 
around the distal phalanx of the index finger. The stacking of the BPP sensor over the 
PPG sensor resulted in a vertical spatial alignment for the single-point, simultaneous 
acquisition of the waveforms.  
Table 4.1: The parameters of the Piezo Film Lab amplifier used to measure the BPP 
waveform 
Mode Voltage—1G (50 pF) 
Low frequency of the filter 0.1 Hz 
High frequency of the filter 10 Hz 
Gain 10 dB typical 
Power source 9V Battery 
 
4.1.1.4 The Tonometric Sensor 
The SphygmoCor (AtCor Medical, Australia) tonometry system’s, tonometric 
waveform (SPH) limited version, with an analogue output tonometer, was used to 
capture applanation tonometric data at the radial artery. The output of the system was 
acquired using the SS9LA interface, as an analogue signal, at channel 3 of the Biopac 
MP36R unit.  
4.1.1.5 Miscellaneous Sensors 
Huntleigh Smartsigns LitePlus Vital Signs Monitor was used to measure the brachial 
BP of subjects, using a medium-sized arm cuff, in a seated posture. The Nokia Body 
Cardio scale was used to measure the subject’s weight, in kg. The subject’s height 
was measured with a wall-mount height measurement scale. The subject’s mood 
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(stressed/relaxed), meals, and coffee intake were recorded before and after 
measurements in a questionnaire.  
4.1.2 Data Collection Environment  
All sensors were placed on the subject’s left hand, in a seated posture, with the arm 
on the desk. The temperature was controlled, at 22°C, and the measurements were 
performed in a comfortable environment, as shown in Figure 4.2.  
 
Figure 4.2: Signal acquisition setup environment, showing the actual acquisition of 
subject 7 
4.1.3 Study Protocol 
This study was conducted on a total of 22 healthy volunteers, aged 32  6 years, with 
a mix of ethnic backgrounds. For this study, the experiments were performed in 
accordance with the Helsinki declaration protocol, and ethical approval was obtained, 
as ‘A feasibility study to evaluate a novel method of assessing microcirculatory 
function as a predictor of the risk of Major Adverse Cardiac Events’ ( IRAS Project ID 
166742 approved on April 30, 2020). Subjects were asked to refrain from consuming 
alcohol for 36 hours, meals for 4 hours, and coffee for 2 hours prior to data collection. 
Subjects were asked to remain calm and avoid making any unnecessary movements, 
to reduce motion artefacts and avoid/minimize respiration modulation. No hydrostatic 
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or gravitational variations in the artery under observation occurred, as the subject’s 
arm was maintained on a table, at a fixed location. The data collection protocol is 
illustrated in Figure 4.3. Subject’s data were excluded if the interbeat interval (IBI) did 
not follow similar behaviours across technologies. 
 
Figure 4.3: The data collection protocol 
4.2 Experimental Setup for Heart Rate Variability Comparison 
Study 
4.2.1 Aim and Objective 
The primary aim of the experiment was to test the responsiveness and trackability of 
the BPP waveform against PPG waveform and ECG R-peak by using HRV analysis. 
The objective of the experiment was as follows: 
1- To capture a noise- and artefact-free BPP waveform. 
2- To co-locate the BPP and PPG sensors on the index finger distal phalanx. 
3- To validate the BPP and PPG waveforms against the ECG waveform, for the 
HRV analysis of the cohort. 
4- To investigate the most suitable fiducial point of the BPP waveform that can be 
used as a surrogate for the ECG R-peak 
4.2.2 System Block Diagram 
The system block diagram is shown in Figure 4.4. ECG, PPG, and BPP sensors were 




Figure 4.4: Block diagram of the data acquisition design, using a Biopac MP36R. 
The BPP sensor is shown on the top left, the PPG sensor is in the middle, and the 
ECG sensor is on the right. 
4.2.3 Sensor Placement  
The PPG sensor was placed at the distal phalanx of the index finger, and the BPP 
sensor was strapped on top of the PPG sensor, to spatially align the sensors. A 
schematic image showing the configuration of the co-located PPG and BPP sensors 
configuration is shown in Figure 4.5, and the sensor placement on the subject’s finger 
is shown in Figure 4.6. 
 
Figure 4.5: Schematic diagram illustrating the mounting of the PPG and BPP 




Figure 4.6: PVDF and PPG sensors placed on the subject’s finger 
4.2.4 Validation Sensor 
In this experiment, the standard ECG electrode wereplaced on the subject’s chest, 
was used as the gold standard for the measurement of HRV.  
4.2.5 Fiducial Location of the Waveforms 
Three critical locations in the BPP and PPG waveforms were selected for the analysis, 
which were compared against the ECG waveform. These fiducial points were as 
follows:  
1. The peaks of the BPP and PPG waveforms. 
2. The peaks of the first derivatives of the PPG and BPP waveforms.  
3. The peaks of the second derivatives of the PPG and BPP waveforms. 
 
These fiducial points are the least affected by wave reflection caused by bifurcation 
and peripheral resistance during blood flow in the arterial tree [2]. The fiducial points 




Figure 4.7: ECG waveforms from subject 7 
 
Figure 4.8: PPG waveform fiducial locations and the first and second derivative 
locations, for subject 7 
 




4.2.6 Signal Processing Algorithm 
The data were filtered using  Savitzky-Golay filter, to remove noise from the signals, 
and the fiducial points were marked by taking the peaks of the waveform, the peaks 
of the first derivative, and the peaks of the second derivative, for the BPP and PPG 
waveforms. The R-peak on the ECG signal was detected using the Pans-Tompkins 
algorithm [3], and the data were visually inspected for cardiac arrhythmia. All fiducial 
points were detected, and the beat-to-beat intervals were calculated to perform the 
HRV analysis, using an open-source code [4] that is available online. Finally, statistical 
analyses were performed. 
4.2.7 Comparison Method – Statistical Analysis 
The ECG R-peak was compared against the following parameters, individually, for 
HRV analysis: 
1. PPG peak  
2. PPG peak of the first derivative 
3. PPG peak of the second derivative 
4. BPP peak 
5. BPP peak of the first derivative 
6. BPP peak of the second derivative 
The agreement analysis was performed via Bland-Altman analysis. A regression 
analysis was performed to identify correlations among the parameters, and 
Spearman’s rank correlation analysis was used to validate the lack of bias in the 
regression analysis. 
4.3 Experimental Setup for the Arterial Indexes Comparison 
Study 
4.3.1 Aim and Objective 
This experiment aimed to compare the BPP waveform against the PPG waveform and 
to validate both against the tonometric waveform (SPH), using the SphymoCor 
system. The objectives of the experiment were as follows: 
1- To capture the BPP, PPG, and SPH waveforms.  
2- To compare the arterial indexes in the arterial waveforms. 
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3- To investigate the WK model transfer function for the BPP waveform, compared 
with the SphygmoCor tonometer. 
4.3.2 System Block Diagram 
The system block diagram is shown in Figure 4.10. ECG, PPG, BPP, and SPH sensors 
were used, attached to an MP36R unit for the simultaneous acquisition of arterial 
waveforms. The BP measurement was recorded manually, using a Microsoft Excel 
file. 
 
Figure 4.10: Block diagram illustrating the acquisition unit, using the Biopac MP36R 
unit shown on the bottom, with the sensors shown on the top. 
4.3.3 Sensor Placement  
The PPG sensor was placed at the distal phalanx of the index finger, and the BPP 
sensor was wrapped on top of the PPG sensor fixture and strapped around the distal 
phalanx of the index finger. The stacking of the BPP sensor over the PPG sensor 
provided the spatial and temporal alignment necessary for the single-point 
simultaneous acquisition of arterial waveforms. The tonometric sensor was placed at 
the radial artery, for applanation across the radius bone. A micromanipulator was used 
(Unisense 4958 Denmark) for the unaided human operation during the data 
acquisition, to achieve a consistent minimum acceptable operator index 
(reproducibility of waveform) of 85%. The micromanipulator provided the best 
repeatability and accuracy for signal acquisition during the experiment, as shown in 
Figure 4.11. To prop up the radius, at the wrist, a custom, 3D-printed (using a Fortus 
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380mc 3D Printer), semi-circular wrist clamp was used, as shown in Figure 4.12. The 
radial artery was palpated and marked, to align the tip of the tonometer accurately. 
For each subject, the tonometer vertical pressure was adjusted manually, by observing 
the saturation/clipping effect in the waveform, using the SphygmoCor system suite.  
 
Figure 4.11: Unisense Micromanipulator 4958 
 
Figure 4.12: 3D fixture for holding the subject’s wrist 
4.3.4 Validation Sensor 
The SphygmoCor tonometer was used as the gold standard for the cross-validation of 
the PPG and BPP waveforms.  
4.3.5 Fiducial Points 
The waveforms are shown in Figure 4.13, and the fiducial points [5] of the waveforms 
are marked in Figure 4.14: ‘S’ represents the diastolic peak of blood flow in the artery, 
indicating the aortic valve opening point and the lowest pressure for blood flow; ‘P’ 
represents the systolic peak of blood flow in the artery, indicating the highest pressure 
point for blood flow; ‘T’ represents the tidal wave of blood flow in the artery, indicating 
the reflected wave in smaller arteries; ‘C’ represents the incisura wave of blood flow in 
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the artery, indicating aortic valve closure; ‘D’ represents the dicrotic wave of blood flow 
in the artery which indicates the reflected pressure wave effect on waveform. 
The fiducial points [6] of the second derivative, shown in Figure 4.15, and the APG 
arterial waveform are as follows: the ‘a-wave’ is the pre-systolic positive peak of the 
APG; the ‘b-wave’ is the pre-systolic negative peak of the APG; the ‘c-wave’ is the 
post-systolic crest of the APG; the ‘d-wave’ is the post-systolic trough; and the ‘e-wave’ 
aligns with the incisura wave.  
The augmentation index (AIx), ageing index (AI), stiffness index (SI), reflection index 
(RI), ejection elasticity index (EEI), and dicrotic reflection index (DRI) were calculated, 
using the fiducial points of the BPP, PPG, and SPH waveforms.  
 




Figure 4.14: The fiducial locations for the BPP waveform of subject 11 
 
Figure 4.15: The accelerated BPP waveform fiducial locations of subject 11 
4.3.6 Transfer Function  
The radial artery branches from the wrist to the radial indics artery, in the distal 
phalanx, and was modelled using 2-element and 4-element WK models were 
estimated from the SPH waveform to the BPP waveform. Transfer function parameters 
were estimated using the MATLAB system identification toolbox.  
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4.3.7 Signal Processing 
The text-formatted data were imported into the MATLAB platform (Mathworks, USA), 
for signal processing. Data were manually inspected, to remove artefacts and were 
cropped to obtain noise-free segments. The Pans-Tompkins algorithm [3] was used to 
detect and mark the ECG R-wave, which was used as the gating location for each 
cardiac cycle, for the remaining arterial signals. The PPG, SPH, and BPP signals were 
filtered using a least-squares technique, with a Savitzky-Golay filter, at –3 dB and 41 
Hz. The algorithm was implemented for steady periods of the cohort data, on 10-
second windows, as follows: 
1. All signals were detrended and normalised. 
2. ECG R-peaks were detected. 
3. The ensemble averages of the PPG, BPP, and SPH signals were calculated 
for 10 cardiac cycles and signals within the standard deviation of  1 were 
used. The arterial waveform width for each cardiac cycle was set to 1.4 
times the R-R interval, for each respective cycle.  
4. The SPH, BPP, and PPG foot, peak, tidal, dicrotic notch peak, and foot 
fiducial points were detected. 
5. The SI, RI, AI, AIx, elasticity index (EI), EEI, and DRI were calculated. 
6. The 2- and 4-element WK model transfer function was calculated, using the 
system identification toolbox in MATLAB, for BPP to SPH signals. 
7. The statistical analysis was performed. 
4.3.8 Comparison of the Parameters– Statistical Analysis 
The arterial index of the SPH waveform was compared against those for the PPG and 
BPP waveforms, individually. The agreement analysis was performed, via Bland-
Altman analysis, and inter-rater agreement was performed, via weighted Kappa 
analysis. The regression analysis was used to find correlations among the parameters, 
and the Spearman’s rank correlation analysis was used to validate the lack of bias in 
the regression analysis. 
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4.4 Experimental Setup for the Pulse Transit Time Comparison 
Study 
4.4.1 Aim and Objective 
This experiment aimed to compare the pulse transit time (PTT) between the BPP and 
PPG waveforms. The objectives of the experiment were as follows: 
1- Co-locate the PPG and BPP sensors on the index finger, using two pairs of 
sensors, in-line. 
2- Compute and compare the PTT between the BPP and PPG waveforms 
4.4.2 System Block Diagram 
The system block diagram is shown in Figure 4.16. Two PPG and two BPP sensors 
were attached to an MP36R unit, to simultaneously capture the signals.   
 
Figure 4.16: The sensor block diagram was used for the subject’s data acquisition 
4.4.3 Sensor Placement  
Two PPG sensors were placed at the index finger, at the radial indices artery, and two 
BPPs were wrapped around the PPG sensors. A schematic for the sensors is shown 




Figure 4.17: A schematic diagram, showing the lateral and cross-sectional views of 
the in-line sensor placement. 
4.4.4 Fiducial Points 
The peak of the first derivative, for each sensor, was marked, and the peak-to-peak 
delay between similar sensors was calculated. 
4.4.5 Cross Comparison – Statistical Analysis 
The cross-comparison between techniques was performed, to identify the most 
suitable physiological parameters and hence the sensing system for the application. 
The skewness was tested, and a repeated-measures ANOVA was performed, to 
identify significant differences between the PTT-BPP and PTT-PPG values. 
Agreement analysis and regression analysis were performed.  
4.4.6 Signal Processing Algorithm 
The signals captured from the acquisition unit, by using Acqknoweldge software, were 
exported in text format to MATLAB (R2018, MATLAB Inc.) software. The data were 
visually inspected, to remove artefacts, and cropped, to obtain clean signals. Savitzky-
Golay filter was used to remove noise and higher frequency components. The steps 
of the algorithms are listed, as follows:   
1- All signals were normalised and detrended. 
2- The peaks of the first derivatives were calculated for all signals.  
3- The PTTs were compared between the BPP and PPG waveforms. 
4- The differences between the PTT values of each methodology were calculated. 
5- The statistical analysis was performed. 
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4.5 Experimental Setup for the PWV and AIx Comparison Study – 
Data Fusion 
4.5.1 Aim and Objective 
The experiment aimed to test the data fusion possibilities for the BPP and PPG 
waveforms; therefore, the objectives are as follows: 
1- Formulate a PU-loop, using the BPP and PPG waveforms.  
2- Use the slope method to calculate the PWV. 
3- Compute the Lissajous figure and calculate the phase-delay between the 
waveforms. 
4- Validate the PWV and the phase-delay against the SphygmoCor Aortic Aix, 
using statistical comparison methods. 
4.5.2 System Block Diagram and Sensor Placement  
The experimental setup and sensor placement were identical to the experimental 
setup for the hemodynamic index study, except that the data from the SphygmoCor 
was captured in the SphygmoCor System Suite for the calculation of the aortic AIx. 
4.5.3 Validation Sensor 
The SphygmoCor system was used for the cross-validation mechanism, for the data 
fusion between the BPP and PPG waveforms.  
4.5.4 Signal Processing Algorithm 
The data acquired by the Biopac Acknowledge software was exported in Excel format, 
for processing in the MATLAB environment in PC (Window 10 OS). The algorithm 
steps used are described below: 
1- A Savitzky Golay filter was used to remove the noise and determine the 
differences between the pressure and volume waveforms.  
2- The ECG waveform R-peak was detected, using the Pan-Tompkins method [3]. 
3- BPP and PPG waveforms were ensembled, by gating the R-peaks, to remove 
signals outside of the standard deviation of  1. 
4- The PU-loop was formed by plotting the difference between the BPP and PPG 
waveforms. 
5- The PU-loops were normalised, and the slopes were manually drawn between 
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early systole (20%–30% of the BPP waveform). 
6- The Lissajous figure was used to measure the phase lag and was normalised at 
an HR of 75 bpm 
7- The statistical analysis was performed. 
4.5.5 Comparison Method 
The trends were compared between the data-fused PWV and the BP of the pilot study 
cohort. An agreement analysis was performed, via the Bland-Altman analysis, 
between the phase-lag and aortic AIx. The regression analysis was used to identify 
correlations between the phase-lag and the aortic Aix, and the Spearman’s rank 
correlation analysis was used to validate the lack of bias in the regression analysis. 
4.6 Summary 
This chapter described the experimental designs used to collate a novel dataset for 
the comparison and validation of the various sensors and their waveforms, limited to 
healthy individuals only. The Biopac MP36R acquisition platform and all custom 
interfaces and associated sensors used in the study were described. Then, each 
experiment and their aims were described and their aims and objectives, system block 
diagrams, sensor placements, signal processing algorithms, the fiducial points on the 
arterial waveforms, the statistical methods, and the comparison techniques used to 
validate the arterial waveforms presented. These experimental studies focused on 
comparisons between the BPP sensor waveforms and the PPG sensor waveforms 
and on their validation against various techniques that represent gold standards for 
waveform measurement. First, HRV analysis techniques were used to validate the 
trackability and responsiveness of BPP and PPG sensors against the ECG gold-
standard waveform. Second, the arterial indexes were validated against the 
SphygmoCor gold-standard tonometric waveform. Third, comparisons between the 
waveforms were performed, based on individual PTT measurements. And finally, the 
PU-loop and phase lag techniques were used to validate the fusion of information 
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Results and Discussions 
5.1 Results for the Experimental Study Examining Heart Rate 
Variability Comparisons 
The HRV analysis was used to compare the trackability and responsiveness of the 
BPP waveform against those of the PPG waveform and were validated against the 
ECG waveform, which is the gold standard for HRV analysis. The fiducial locations on 
the arterial waveforms that were used for the beat-to-beat intervals (B2BI) were the 
systole peak-to-peak interval, the first derivative peak to first derivative peak interval, 
and the second derivative peak to the second derivative peak interval, which were 
validated against the ECG waveform R-peak to R-peak interval, to examine the HRV 
analysis parameters. The significant HRV analysis parameters that were used for 
these comparisons are presented in Table 5.1.  
Table 5.1: Time, frequency, non-linear, Poincare, and time-frequency domains of the 
HRV parameters that were used for the comparison analysis 
Time Domain 
SDNN pNN50 RMSSD sdHR HRVTi TINN 
(ms) (%) (ms) (bpm) (ms) (ms) 
Frequency Domain 
Welch periodogram, Auto-Regressive periodogram, and Lomb-Scargle 
periodogram 
pVLF pLF pHF VLF LF HF 
(%) Peak (Hz) 
Nonlinear Domain Poincare 
SampEn alpha alpha1 alpha2 SD1 SD2 
    (ms) 
Time-Frequency Domain 
Auto-Regressive, Lomb Periodogram, and Wavelet Transform 
pVLF pLF pHF VLF LF HF 
(%) Peak (Hz) 
*SDNN= Standard deviation of NN intervals, pNN50= Percentage of successive RR intervals that differ by more than 50 ms, 
RMSSD=  Root mean square of successive RR interval differences, sdHR=Standard deviation HR, HRVTi= HRV triangular index, 
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TINN=Triangular Interpolation of the NN Interval Histogram, VLF=very-low-frequency band, LF=Low-Frequency, HF= High 
Frequency, p=Peak, SampEn=Sample Entropy, SD1= Poincaré plot standard deviation perpendicular the line of identity, SD2= 
Poincaré plot standard deviation along the line of identity alpha = Approximate entropy, which measures the regularity and 
complexity of a time series , alpha1= Detrended fluctuation analysis, which describes short-term fluctuations and alpha= 
Detrended fluctuation analysis, which describes short-term fluctuations. 
The graphical user-interface options used for the HRV analysis software are shown in 
Appendix A, compared against their corresponding waveforms. The baseline noise 
and ectopic beats were removed from the beat-to-beat intervals of each waveform, to 
avoid artefacts during the comparison. The regression analysis was performed to 
determine the associations and the strength of the relationships between the arterial 
waveforms, and Spearman’s rank correlation was used to verify that the regression 
was unbiased. The regression plots showing the ECG vs BPP and ECG vs PPG 
comparisons, for each fiducial point, are shown in Figure 5.1 (a-f). The regression ‘r2’ 
values and Spearman’s ‘rho’ values, along with the significance levels, are tabulated 
in Table 5.2, arranged in ascending order based on the ‘r2’ value.  
Table 5.2: Regression analysis and Spearman’s rank correlation for HRV parameters  
ECG R-peak 
 Regression Spearman’s Rank Correlation 
 r2 rho Significance level 
PPG peak 0.9720 0.995 P < 0.0001 
BPP second derivative peak 0.9659 0.984 P < 0.0001 
PPG second derivative peak 0.9562 0.990 P < 0.0001 
BPP peak 0.9484 0.990 P < 0.0001 
BPP first derivative peak 0.9398 0.987 P < 0.0001 
PPG first derivative peak 0.9247 0.988 P < 0.0001 
 
The results for a cohort of 6 subjects, aged 34  6 years, who were all male, showed 
that the highest overall ‘r2’ parametric fit was for the PPG waveform peak B2BI, 
followed by the BPP second derivative peak B2BI, whereas the lowest r2 value was 
for the PPG first derivative peak B2BI, compared with the ECG R-peak to R-peak, for 
the HRV analysis. The highest Spearman’s rank correlation ‘rho’ values were also 
found for the PPG Peak B2BI and the BPP peak B2BI, whereas the lowest values 
were for the BPP second derivative peak B2BI. All the fiducial locations used for the 
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PPG and BPP waveforms showed very strong and significant positive associations 
with the ECG waveform, for all the HRV analysis parameters, based on the linear 
regression analysis.  
Figure 5.1: The regression analysis showing the ECG R-peak (ECG) vs a) the BPP 
Peak (BPP_P), b) PPG peak (PPG_P), c) BPP first derivative peak (BPP_1D), d) PPG 
first derivative peak (PPG_1D), e) PPG second derivative peak (PPG_2D), and f) BPP 
second derivative peak (BPP_2D), individually, for the HRV analysis parameters 
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The agreement analysis was performed via a Bland-Altman analysis, and the plots are 
shown in Figure 5.2. The Bland-Altman systematic difference and the limits of 
agreement (LoA) are tabulated in Tables 5.3 and 5.4, respectively. All parameters in 
the agreement analysis rejected the null hypothesis, with p-values < 0.0001. The mean 
differences between the parameters observed in the Bland-Altman analysis were not 
significant distant from zero. The lowest systematic difference was identified for the 
BPP second derivative peak B2BI, whereas the highest difference was identified for 
the PPG first derivative peak B2BI. The lowest LoA was found for the PPG peak B2BI, 
whereas the PPG first derivative peak B2BI presented the highest LoA.  
Table 5.3: The systematic differences in HRV, with reference to fiducial points  
The fiducial locations of 
B2BI                  n 
Differences against ECG R-peak B2BI 
Mean SD 95% Confidence interval 
BPP_P 288 -0.3320 7.4359 -1.1944 to 0.5304 
 BPP_1D 288 -0.4252 8.0396 -1.3576 to 0.5073 
 BPP_2D 288 -0.1401 5.9479 -0.8299 to 0.5498 
PPG_P 288 -0.3400 5.6266 -0.9926 to 0.3126 
PPG_1D 288 -0.4946 8.9467 -1.5323 to 0.5430 
PPG_2D 288 -0.1688 6.8504 -0.9633 to 0.6258 
 
Table 5.4: The limits of agreement among the HRV parameters, with references to 
fiducial points 
Variable 
Limits of agreement against ECG R-peak B2BI 
Lower limit 95% Confidence interval Upper limit 95% Confidence interval 
BPP_P -14.9064 -16.3820 to -13.4308 14.2424 12.7668 to 15.7180 
BPP_1D -16.1828 -17.7782 to -14.5874 15.3324 13.7370 to 16.9278 
BPP _2D -11.7979 -12.9782 to -10.6176 11.5178 10.3375 to 12.6981 
PPG_P -11.3681 -12.4846 to -10.2515 10.6881 9.5715 to 11.8046 
PPG_1D -18.0301 -19.8055 to -16.2547 17.0408 15.2654 to 18.8162 




Figure 5.2: Combined B2BI Bland-Altman analyses of the ECG RR vs BPP waveform 
peak, first derivative, and second derivative and the ECG RR vs PPG waveform peak, 
first derivative, and second derivative, for HRV analysis 
5.1.1  Discussion 
HRV analysis has been very important in the early detection of cardiovascular disease. 
In the last decade, researchers have been examining potential ECG sensor 
alternatives, such as the PPG sensor, and this study represents an alternative  in 
which the BPP sensor was tested for its responsiveness and trackability to perform 
HRV analysis compared with the ECG waveform. 
PPG sensors have been widely applied both in intensive care units and GP clinics. 
Researchers have aimed to extract multiple streams of information from this sensor. 
PPG is very common in the wearable ambulatory setting, measuring HR and related 
parameters. PPG sensors perform very poorly in some situations, such as when the 
sensor makes poor contact with the skin due to excessive body movements, and in 
older patients and patients with low blood perfusion in the arteries. The BPP sensor 
can overcome many of these shortcomings but is also prone to motion artefacts, due 
to its high sensitivity.  
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This study focused on various fiducial B2BI locations on arterial waveforms, such as 
the systolic peak, the first derivative peak, and the second derivative peak, which have 
neither been compared simultaneously across different sensing methodologies. This 
novel dataset has unique advantages because all arterial waveform signals are 
processed using the same algorithms, presenting ideal conditions for true 
comparisons. 
This study only focused on comparisons in young, healthy subjects, measured with 
the subject in a static sitting posture because the arterial flow waveforms are detected 
well in these situations and have been known to serve as surrogates for the ECG R-
peak B2BI for HRV analyses [1]. The results of this study highly correspond to 
previously researched outcomes published found in the literature, for both regression 
analyses and agreement analyses, as stated in a review article by Schafer et al. [1]. 
In future studies, motion artefact removal, the validation of waveforms across both 
healthy and unhealthy subjects, and during exercise conditions will greatly add to the 
body of biomedical research knowledge.  
During this comparative study, the BPP second derivative peak B2BI and the PPG 
peak B2BI were found to serve as surrogates for the ECG R-peak B2BI for 
accumulative HRV analysis parameters. These results verify the responsiveness and 
effectiveness of BPP waveforms compared with the state-of-the-art PPG waveforms. 
These results provide confidence for the performance of further investigations that rely 
on arterial waveform morphological analyses.  
5.2 Results for the Experimental Study Comparing Arterial Indexes  
Comparisons were performed for the AIx, AI, SI, RI, EEI, and DRI, on a cohort of 11 
healthy subjects, aged 36  6 years, who were all male. The agreement analysis was 
performed via Bland-Altman analysis, comparing 1) PPG waveform arterial indexes 
with SPH waveform arterial indexes, and 2) BPP waveform arterial indexes with SPH 
waveform arterial indexes, individually, as shown in Figure 5.3, arranged in ascending 
order with respect to LoA scores and tabulated in Table 5.5. The indexes calculated 
from the BPP waveforms demonstrated a narrower/closer limit of agreement (LoA) 
than indexes calculated from the PPG waveform, compared to the SPH waveform, 
individually. The index comparison, based on LoA, highlighted the increased accuracy 
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of the BPP waveform compared with that of the PPG waveform, with RI and AIx 
presenting the closest/narrowest LoA and EEI showing the highest LoA. 
 
Figure 5.3: The Bland-Altman Analysis of Indexes, BPP vs SPH (on left) and PPG vs 




To validate the trends shown by the Bland-Altman analysis, a weighted Kappa analysis 
(WKA) was used. In the WKA, among the various indexes, compared between SPH 
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waveforms and BPP waveforms, the AI and SI indexes (at the top, in ascending order) 
showed moderate relationships, whereas the remaining indexes showed fair 
relationships, except for RI which showed only a slight relationship. The WKA among 
various indexes, compared between the SPH waveform and the PPG waveform, 
showed that AIx, AI, EI, and EEI showed fair relationships, whereas the remaining 
indexes showed no relationship (none < 0. 2> slight < 0.4 > fair < 0.6 > moderate < 
0.8 > perfect < 1). 
Table 5.6: The regression and Spearman’s rank analyses for arterial indexes. SPH 
against BPP is shown on the left and SPH against PPG is shown on the right 


















AIx BPP1 P < 0.0001 0.925 0.702 AIx PPG7 P = 0.0093 0.666 0.5125 
EI BPP2 P < 0.0001 0.903 0.5625 EI PPG9 P = 0.0138 0.64 0.5041 
SI BPP3 P < 0.0001 0.895 0.8628 SI PPG4 P < 0.0001 0.895 0.00418 
EEI BPP5 P < 0.0001 0.881 0.5705 EEI PPG10 P = 0.0246 0.596 0.499 
AI BPP6 P = 0.0012 0.771 0.4959 AI PPG11 P = 0.0666 0.503 0.1318 
DRI BPP8 P = 0.0138 0.64 0.3746 DRI PPG13 P = 0.9346 0.0242 0.0788 
RI BPP12 P = 0.2269 0.345 0.2347 RI PPG14 P = 0.8286 -0.0637 0.01566 
*Ascending order, based on the rho values among the Indexes 
 
Individual regression analyses were performed to identify correlations among the 
indexes associated with the BPP and PPG waveforms and those for the SPH 
waveform. The plots are shown in Figure 5.4. Similar results were observed for the 
regression analyses as were observed for the Bland-Altman analysis, with BPP 
waveform indexes showing stronger correlations with the SPH waveform indexes than 
the PPG waveform indexes. When the regression values were arranged in ascending 
order, the SI, AIx, EEI, and EI of the BPP waveforms showed the strongest 
correlations. Spearman’s rank correlation was used to validate the trends identified by 
the regression analysis. The Spearman’s rank correlation between the indexes of the 
BPP waveform and those of the SPH waveform showed that AIx, EI, SI (in ascending 
order), and EEI showed very strong positive correlations, whereas AI and DRI showed 
a strong correlation, and RI showed moderate correlation. In the Spearman’s 
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correlation between the indexes of the PPG waveform and those of the SPH 
waveform, SI showed a strong positive correlation, whereas AIx, EI, EEI, and AI 
showed moderate positive correlations, and the remaining indexes showed very weak 















Figure 5.4. The regression analyses of arterial indexes, comparing the SPH waveform 
against the BPP waveform (left) and the PPG waveform (right) 
5.2.1 The 2- and 4-element Windkessel (WK) Transfer 
Functions 
For the radial artery, which branches from wrist to the distal phalanx in the index finger, 
the 2- and 4-element WK models were estimated for transforming the BPP waveform 
into an SPH waveform, using the MATLAB system identification toolbox. The 
parametric mean and standard deviation for the cohort is shown in Table 5.7. The 
accuracies of the individual transfer functions for the 2-element WK model were all 
higher than 85%, and the accuracies of the individual transfer functions for the 4-
element WK model were all higher than 98%, as shown in Table 5.8. 
Table 5.7: The 2- and 4- element WK model transfer functions and their parametric 
average values, for all subjects in the trial 
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Table 5.8: Estimation accuracies of the 2- and 4-element WK models, for 
personalised transfer functions 
Subjects 4-element WK accuracy (%) 2-element WK accuracy (%) 
1 98.43 88.94 
2 96.76 88.87 
3 98.33 88.22 
4 96.07 77.64 
5 97.62 76.76 
6 98.1 83.26 
7 98.18 88.09 
8 96.96 77.57 
9 98.18 83.76 
10 98.91 87.78 
11 96.94 83.9 
 
5.2.2  Discussion  
The BPP AIx index performed the best compared with the SPH waveform, for all 
parameters examined. The overall best performances were obtained for the AI, EEI, 
and SI indexes for the BPP waveform, which agrees with the parametric results 
reported by Wowern et al. [2]. However, in our study, BPP outperformed PPG for all 
indexes, both individual and overall. The DRI showed a weak but significant 
relationship, whereas RI showed almost no significant relationship among the 
examined BPP parameters. 
The APG demarcation of the fiducial wave is mathematically complex and intensive 
and becomes even more difficult for the PPG waveform, as the tidal wave is not very 
visible. In contrast, for the BPP waveform, the tidal wave was visible in all subjects. 
This inconsistency has also been reported elsewhere [3]. The dicrotic notch and the 
tidal wave are both consistently visible in the BPP waveform, as observed in this study, 
which makes the BPP waveform superior to the PPG waveform.   
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The clinical associations have been well-established in the literature for the AIx and AI 
indexes [2][4] and their relationships with CVD; however, the reverification or 
establishment of any such relationships among healthy and diseased groups was 
outside of the scope of this study. 
Due to the high sensitivity of the PVDF sensor to mechanical vibration, BPP waveform 
sensing may be limited to stable postures, to avoid motion artefacts. Identifying a 
method that allows the BPP measurement to be measured and  signal information to 
be extracted even in the presence of motion artefacts remains an important 
developmental goal. 
The 2-element WK model represents a simple function and can be easier to interpret 
for person-specific parameters, which may make adaptive tracking possible (which is 
suggested for future work), as has been suggested by Mukkamala et al. [5]. 
BPP is independent of the subject’s skin colour and cosmetic effects on the skin 
surface, unlike the PPG waveform. BPP can also be performed in an operator-less 
manner, which makes it an attractive method compared with the SPH waveform. 
In conclusion, the BPP waveform measurement technique is advantageous because 
it can be performed unaided and is cheaper and easier to use than conventional 
tonometric devices. BPP waveforms also outperform the conventional PPG waveform 
for all indexes. As it can be incorporated into wearable technologies, thus the better 
assessment of arterial indexes, the BPP waveform may facilitate the early detection 
and prevention of CVD. 
5.3 Results for the Experimental Study Comparing the Pulse 
Transit Time 
The PTT-PPG, PTT-BPP, and their trend plots, using the 9th order polynomial, are 
shown in Figure 5.5. The cohort data obtained on 7 subjects, aged 32  4 years, who 
were all male, showed higher average PTT-BPP valuesan increase of 11 ms, 
compared with that for PTT-PPG. The data from three subjects were discarded from 
the analysis as their PTT-PPG waveforms showed cross-over with the PTT-BPP 
waveforms with no observable physiological changes were observed in the subject’s 




Figure 5.5: PTT-PPG and PTT-BPP values of the cohort, and their data trends 
The histograms for PTT-BPP and PTT-PPG are calculated, as shown in Figures 5.6 
and 5.7, respectively. Both waveforms showed normal distributions, as can be 
observed in the dotted waveform on the plots. The data were tested for skewness and 
none was found, for either the PTT-BPP or the PTT-PPG cohort datasets.  
 




Figure 5.7: Histogram of PTT-PPG and its normal distribution  
The PTT-PPG and PTT-BPP cohort datasets were tested using a repeated-measures 
ANOVA, and tests between subjects showed low p-values for both groups (p < 0.05), 
as shown in Table 5.10. Based on the p-values, there is a significant difference 
between the groups. A plot of the means, clustered by groups, is shown in Figure 5.8. 
The PTT-BPP waveform showed consistent behaviour, with a low standard deviation, 
for mean values, indicating that the measurement of the arterial waveform, based on 
the distension waveform, was consistent. Plotting the PTT-PPG against the persistent 
PTT-BPP plots showed intermittent behaviour for the PTT-PPG intervals, indicating 
weakness in tracking the waveform compared with the PTT-BPP. 
 
Figure 5.8: Repeated measures ANOVA plot between PTT-PPG and PTT-BPP 
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Groups (Subjects) 0.000185 6 0.0000309 2.27 0.037 
Residual 0.00478 351 0.0000136   
 
An agreement analysis was performed using a Bland-Altman analysis, as shown in 
Figure 5.9. The value of the LoA and the systematic differences are tabulated in Tables 
5.11 and 5.12, respectively. Most of the dataset remains within the 95% confidence 
interval, although some outliers can be observed. No biases were detected in the 
dataset, as the systematic mean difference was near-zero, at 0.01097.  
 
Figure 5.9: Bland-Altman analysis comparing PTT-BPP vs PTT-PPG for the cohort 
Table 5.10: The Bland-Altman limit of agreement 
Bland-Altman analysis Limits of agreement 
Lower limit 95% Confidence interval Upper limit 95% Confidence interval 




Table 5.11: The Bland-Altman systematic difference  
Bland-Altman analysis differences (%) 
Mean SD 95% Confidence interval 
0.01097 0.006132 0.01033 to 0.01161 
 
To examine the relationship between the PTT-PPG and the PTT-BPP, regression 
analysis was performed, as shown in Figure 5.10. The regression analysis biases were 
tested using Spearman’s rank correlation. Both analyses showed a very weak 
relationship, as expected, based on the non-consistent behaviours shown between 
the subjects’ PTT-PPG and PTT-BPP.   
 
Figure 5.10: The regression analysis for PTT-PPG vs PTT-BPP 
Table 5.12: The regression analysis and Spearman’s rank correlation 
PPG vs BPP for all subjects 
 Regression Spearman’s Rank Correlation 
Sample size r2 rho Significance level 
358 0.02405 -0.160 P = 0.0024 
 
5.3.1  Discussion 
The development of a non-invasive assessment for arterial stiffness has been of great 
interest during the last decade, especially with the rise of wearable technologies. The 
124 
 
PTT has shown higher estimation accuracies for the assessment of both SBP and 
DBP values. Research has focused on optical sensing, but no comparisons have been 
performed across different sensing methodologies, as researched in this study. A 
unique and novel comparison of PTT measurements has been presented, which may 
represent the first attempt to compare PTT between PPG and BPP sensing 
methodologies.  
 According to Womersley’s arterial flow [6], the flow waveform lags the pressure wave 
by 90° in larger arteries. The BPP waveform sensing of distension waveforms can be 
directly associated with the pressure waveforms [7], which improves the assessment 
of PTT and reduces estimation errors. According to the results shown in Figure 5.8, 
the PTT-BPP has a steadier and faster response than the conventional PTT-PPG, 
which may improve the BP estimation accuracy based on PTT [8][9][10].  
No viable source of cross-validation was available for these measurements, but the 
results can be supported by the experimental study of arterial indexes. The BPP 
waveform was validated against the SphygmoCor waveform and outperformed the 
PPG for the measurement of haemodynamic indexes, including the AIx, the AI, and 
the SI.  
The PPG sensor measures the volumetric blood flow waveform, based on the 
oxygenation absorption of haemoglobin, which can vary, even for similar blood 
volumes. In this comparison, the IR wavelength used to measure the PPG waveform 
was less sensitive to oxygenation [11] levels but was not free from related artefacts. 
In contrast, the BPP waveform relies on the distension waveform, which does not 
produce artefacts associated with the oxygenation level of the blood, making it a 
superior investigation method. 
The PTT-PPG graph showed cross-over with the PTT-BPP graph in three excluded 
subjects, which highlights the inconsistency of tracking PTT using the PPG waveform, 
whereas the PTT-BPP showed steadier behaviour. In the absence of any interventions 
intended to change BP, the existence of cross-over raises issues regarding the 
credibility of using PPG technology for the measurement of PAT/PTT-like parameters.  
In conclusion, the higher precision and accuracy of the BPP waveform for sensing the 
morphology of the arterial waveform encouraged the comparison between BPP and 
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PTT measured using current state-of-the-art technology. A significant difference was 
observed between PTT-PPG and PTT-BPP, and higher consistency was found for the 
PTT-BPP values. Interestingly a very weak correlation was found among the dataset, 
and no biases were found in the agreement analysis. 
5.4 Results for the Experimental Study Comparing PWV and AIx - 
Data Fusion 
In the first section of this study, data was collated from 6 subjects, aged 34  4 years 
(all male), and their absolute, unitless PWVs were calculated using PU-loop plots. The 
signal processing algorithm was applied to extract the ensemble averages of the 
arterial waveforms (BPP and PPG) and normalised PU-loop plots. An example of 
signal processing performed for subject 3 is shown in Figure 5.11. The slope was 
calculated based on 20%–30% systole for the BPP waveform on the PU-loop plot, 
resulting in the PWV, which is tabulated in Table 5.13. The normalised PU-loops for 
all subjects are shown in Figure 5.11. An increasing trend was observed for PWV with 
increasing BP. This absolute, unitless PWV measurement was derived from the 
normalisation of the ensembled arterial waveforms, which can predict changes in BP, 
based on PU-loop morphology.  
Table 5.13: Dataset parameter and normalised PWV results 
BP 1 BP 2 Age H(cm)/W(kg) BMI PWV (unitless) 
139/98  137/96 45 175/85  27.76 2.89 
118/77  125/77 29 177/80  25.54 2.00 
116/71  116/73 32 174/78  25.76 1.75 
121/71  127/72 30 180/83  25.62 1.28 
119/66  115/73 27 188/73  20.65 1.11 





Figure 5.11: The ensembled average for subject 3, PPG signals (top right), BPP 
signals (bottom left), PWV slope (top left), and cohort PU-loop and local PWV (bottom 
right) 
In the second part of the study, the phase lag between the BPP waveform and the 
PPG waveform was calculated, using a Lissajous figure plot, on cohort data from 12 
healthy subjects, aged 36  4 years (all male). The phase lag was normalised at an 
HR of 75 bpm, to confirm it with the value of the aortic AIx (adjusted at an HR of 75 
bpm), taken from the SphygmoCor system, as shown in Figure 5.12. 
 
Figure 5.12: Lissajous Figure of the BPP and PPG waveform  
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The regression analysis showed a significant association with an ‘r2’ value of 0.71 
between the phase-lag and the aortic AIx. The lack of bias was tested using 
Spearman’s rank correlation, which showed stronger strength in a positive direction. 
The results are tabulated in Table 5.14, and the linear fit of the regression parameter 
is shown in Table 5.15.  
 
Figure 5.13: The regression analysis between Phase Lag and Aortic AIx 
Table 5.14: The regression analysis and Spearman’s rank correlation  
Aortic AIx Vs Phase Lag - @ HR 75 bpm 
 Regression Spearman’s Rank Correlation 
Sample size r2 rho Significance level 
12 0.7099 0.779 P = 0.0028 
 
Table 5.15: The regression line equation and parameters 
Regression Equation 
y = -16.0993 + 45.2304 x 
Parameter Coefficient Std. Error 95% Confidence interval t P 
Intercept -16.0993 5.9860 -29.4369 to -2.7617 -2.6895 0.0227 




The Bland-Altman agreement analysis was performed, and the plot is shown in Figure 
5.14. The LoA and systemic difference values are tabulated in Tables 5.16 and 5.17, 
respectively. In the agreement analysis, bias was observed in the dataset, as the mean 
difference did not equal zero, which is the ideal value. To resolve this bias, the data 
difference was regressed around the mean of the groups, and the linear fit parameters 
are shown in Table 5.18. 
 
Figure 5.14: The Bland-Altman analysis between Aortic AIx and Phase Lag 
Table 5.16: The Bland-Altman limits of agreement  




Upper limit 95% Confidence interval 
82.0960 88.2066 to 75.9853 103.5243 109.6350 to 97.4136 
 
Table 5.17: The Bland-Altman systematic differences 
Bland-Altman analysis- Differences (%) 
Mean SD 95% Confidence interval 






Table 5.18: The Bland Altman analysis regression line parameters 
Bland-Altman analysis - Regression line 
Regression Equation y = 85.2774 + 0.5832 x 
Parameter Coefficient SE t P 95% Confidence interval 
Intercept 85.2774 2.1612 39.4588 <0.0001 80.4620 to 90.0928 
Slope 0.5832 0.1470 3.9666 0.0027 0.2556 to 0.9108 
 
5.4.1  Discussion 
The non-invasive assessment of BP, using PAT or PTT techniques, shows a close 
relationship with BP, often fails to track sudden changes in BP. The current 
methodology of cuffless BP monitoring requires frequent brachial BP inputs to 
calibrate the measurement. This work attempted to contextualise the calibration 
requirement by using PWV and/or phase-lag for the PTT estimation of BP. These 
results will provide adaptive feedback for the correcting factor in the Moen-Korteweg 
PWV equation, as suggested by the author [12]. 
The mandate of the study was to explore the feasibility of formulating a PU-loop and 
phase-lag calculation, to act as a calibration mechanism. The quantisation of the BPP 
and PPG waveforms is necessary to obtain greater insights into the biomechanical 
markers. In the current method, the normalised waveforms were used to evaluate the 
morphology of the PU-loop among the subjects (suggested future work should 
compare hypertensive and normotensive groups). The hydrostatic and gravitational 
effects were neglected in these experiments, based on the assumption of similar sitting 
postures in an armchair, for all subjects. The BPP sensor scalability and repeatability 
of the experiment were very encouraging.  
This method is advantageous because it can estimate the AIx from a single location, 
noninvasively, compared with the conventional measurement using the SphygmoCor 
system. This method is operator-independent, cheaper and well-suited for 
development based on wearable applications.  
130 
 
The non-invasive measurement of phase-lag at a distal artery highly correlates with 
the results reported by Womersley et al. [6], which also implies the superiority of the 
BPP waveform compared with the PPG waveform.   
In conclusion, a novel, non-invasive, single-location assessment method for PWV and 
phase lag has been developed. The results successfully demonstrated that the phase-
lag between the BPP and PPG waveforms was strongly correlated, with an ‘r2’ value 
of 0.71, with the aortic Aix, as measured using the SphygmoCor tonometric device. 
5.5 Summary 
In summary, a novel dataset was collated containing arterial waveforms detected 
using various sensing methodologies. The sensing methodologies were based on the 
volumetric waveform, the distension waveform, and the tonometric waveform of 
arterial waveforms, facilitating a unique, cross-methodology comparison and 
validation. A novel sensor, the BPP, was compared against the state-of-the-art PPG 
sensor and validated against various gold standards. The results of experimental 
studies comparing HRV evaluation methods laid the foundation for this present 
research study, which validated the responsiveness and trackability of a BPP sensor 
against the gold-standard ECG waveform. The results of the experimental study 
comparing arterial indexes demonstrated the higher accuracy and precision of the 
BPP sensor waveform compared with the state-of-the-art PPG sensor waveform. The 
BPP sensor waveform was validated against the gold standard tonometric device 
waveform. Furthermore, this study established the feasibility of developing an 
operator-independent and wearable surrogate for the tonometric device. The results 
of the experimental study comparing PTT values highlighted the shortcomings of the 
current state-of-the-art PPG sensor and showed the superiority, stability, and 
consistency of the BPP sensor waveform for the assessment of PTT. Finally, the 
results of the experimental study comparing PWV and AIx values were used to devise 
and verify a novel data fusion method, for the single-location assessment of arterial 
stiffness, which may help track sudden changes in BP using PTT techniques. These 
results will assist with the prognosis and diagnosis of CVD, using a cuffless BP 
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Conclusion and Future work  
 
6.1 Conclusion  
This study compared and validated a novel, non-invasive sensing system for the 
assessment of arterial stiffness, an indicator of hypertension, and has contributed 
significantly towards improving the conventional techniques for cuffless BP estimation 
used for early detection of hypertension. Furthermore, this study verified and 
highlighted the advantages of mechanical sensing for the arterial distension waveform, 
demonstrating that BPP is superior to the current state-of-the-art optical PPG 
assessment of arterial waveforms. This study also explored pathways for collating a 
novel, state-of-the-art dataset that simultaneously captured various modalities of the 
arterial waveform signals, such as PPG, BPP, SPH, and ECG. The BPP and PPG 
arterial waveforms were compared and validated against various gold-standard 
waveforms and techniques. 1) HRV techniques, precursor to hypertension, were used 
to compare the arterial waveforms, to determine their trackability and responsiveness 
in the arterial tree and were validated against ECG waveforms. 2) The spatial-temporal 
indexes, predictor of hypertension, of arterial waveforms were used to compare 
waveform morphologies and were validated against the SPH waveform. 3) The inter- 
and intra-methodology comparisons of PTT measurements were used to compare the 
consistency and stability of using arterial waveforms for arterial stiffness 
measurements. Finally, 4) The fusion of PPG and BPP waveforms was tested, using 
phase-lag and PU-loop techniques, which were validated against the SphygmoCor 
aortic AIx. 
This study developed a novel acquisition platform, which was able to integrate various 
state-of-the-art sensors, for the simultaneous acquisition of arterial waveforms with 
different morphologies, such as the PVDF sensor system (using the BPP sensor) to 
obtain a BPP waveform, an SPH device to obtain the arterial tonometric waveform, 
and a PPG sensor, to obtain a volumetric flow waveform, using the Biopac MP36R 
research platform. This study developed a processing algorithm, to eliminate artefacts 
134 
 
and unknowns associated with processing, during the comparison of and validation of 
arterial waveforms, which may be unavoidable if different software is used.  
One of the key advantages of the BPP sensing technique is that it is not influenced by 
blood rheology and/or changes in blood rheology, compared with conventional 
techniques, such as PPG. In addition, BPP operates independently of the subject’s 
skin colour and is free from artefacts caused by for example, the use of cosmetics, 
unlike the PPG sensor. These advantages make BPP more appropriate method for 
the assessment of arterial waveforms compared with PPG. 
The BPP sensor can be used as a surrogate for the gold standard for HRV, ECG R-
peak, during the assessment of the HRV. The peak of the first derivative and the peak 
of the second derivative of the PPG and BPP waveforms showed satisfactory 
accuracies (r2 >0.9) compared with the ECG R-peak HRV parameters. The peak of 
the second derivative of the BPP arterial waveforms proved to be the most resilient 
against arterial tree artefacts, with the highest ‘r2’ value when correlated with the ECG 
R-peak for HRV. This result established the trackability and responsiveness of BPP 
arterial waveforms, which can produce a similar efficiency and performance for the 
measurement of HRV parameters against the gold-standard ECG waveform. The 
fiducial point on the BPP arterial waveform did not alter haemodynamic parameters in 
response to artefacts from the arterial tree. 
The BPP sensor can be used as a low-cost, tonometer, prognosticator of 
hypertension, alternative because the BPP waveform showed high accuracy for the 
assessment of arterial indexes, including the SI, RI, AI, AIx, EI, EEI, and DRI, 
compared with PPG waveform indexes, which were validated against the SPH 
tonometric waveform indexes. The dicrotic notch plays a vital role in the assessment 
of these indexes, which were not present in the PPG arterial waveforms. In contrast, 
the BPP-sensed waveform was successfully able to capture the dicrotic notch in all 
the subjects in the study. The use of the 4-element WK personalised transfer function 
on the BPP waveform increased the accuracy of the indexes to 98% compared with 
the SPH tonometric waveform indexes. Additionally, the BPP sensor is an operator-
less, lightweight, wearable, and low-cost sensor that can be used for the accurate 
assessment of arterial stiffness, as a low-cost alternative to tonometric devices. 
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Novel inter- and intra-group comparisons of PTT were performed between inline BPP 
sensors and inline PPG sensors. This study is the first to compare methodologies for 
the detection of the arterial waveform. The BPP waveforms showed an improved 
consistency and stability for PTT measurements on the arterial branch compared with 
the PPG waveforms. PTT-BPP showed higher transit time values compared with PTT-
PPG, with an average mean value of 11.5 milliseconds. The ANOVA identified a 
significant difference between PTT-PPG and PTT-BPP values, which supports and 
verifies the comparisons among the spatial-temporal indexes. The higher consistency 
of PTT-BPP may improve BP estimation accuracy, which can help to independently 
predict sudden changes in BP measurements. 
Finally, the fusion between the BPP and PPG waveform was examined, producing a 
PU-loop and a phase-lag measurement between the waveforms, which was validated 
against the SPH carotid AIx. The phase-lag between the BPP and PPG waveforms is 
highly correlated with the SPH carotid AIx, which has great prognostic value. The 
fusion method resulted in the development of a novel, single-location, non-invasive 
arterial stiffness assessment method, which has enormous potential for the future 
development of compact wearable devices for early detection of hypertension.  
6.2 Future Directions 
This work can be further improved and would be beneficial for designing emerging and 
novel devices in the future for prognosis of hypertension. The following 
recommendations are based on the experience gained during this research study. 
1- Motion artefact removal would be the most attractive research area, which is 
necessary to make the PVDF piezoelectric sensor truly wearable. Enormous 
research is focused on motion artefact removal for the PPG waveform [1], which 
can also be applied to the BPP waveform. 
2- The personal or general adaptive tracking function has been the focus of 
research, due to the dynamic nature of BP waveforms, as reported by 
Mukkamala et al. [2], and has the potential to transform the PVDF piezoelectric 
sensor into a tonometric device that can dynamically track haemodynamic 
parameters related to hypertension. 
3- The quantisation of the PVDF piezoelectric sensor would provide insights into 
BP variations, in mmHg, which would add value to the morphological waveform. 
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4- The comparison between hypertensive subjects and same-aged healthy 
subjects may improve the stratification between these two categories. 
5- BPP waveform validation, using BP intervention techniques, such as the 
Valsalva and Muller’s manoeuvres, have the potential to improve estimates of 
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Figure 5.1A: Parameter setting of HRVAS 
 




Figure 5.3A: The parameters for HRV  in the time domain 
 









Figure 5.6A: The HRV parameter in the nonlinear domain 
o  
Figure 5.7A: The HRV analysis in the frequency domain based on different PSD 
